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With more number of individuals becoming health conscious, the use of biosensors for medical 
diagnosis is rapidly growing. So far, many efforts have been made to meet this increasing 
demand. This work presents several routes to improve the biosensors performances and builds a 
sophisticated platform for sensing application.  
Single polypyrrole nanowire-based sensors were fabricated using a one-step 
electrochemical deposition method. A shadow mask was introduced to protect the biosensors 
from O2 plasma for the microfluidics integration. The results of nanowire resistance and 
fluorescence intensity indicated that the shadow mask played a key role in protecting the 
biosensor. The microfluidic aptasensors were consequently developed. The sensor demonstrated 
excellent specificity and sensitivity with faster response and rapid stabilization times.  
High yield polyaniline 1D nanowires and 2D nanobelts were fabricated by combining 
nanofabrication techniques and a chemical synthesis method. The PANI patterns possess good 
uniformity in morphology and electrical properties. The biosensors were found very sensitive to 
BNP targets, showing a response ~17% for 100 fg/mL BNP and a wide sensing range from 25 
fg/mL to 5 pg/mL. Despite the reduced sensitivity compared to that in PBS, distinguishable 
changes in the FET sensors were observed over a range from 100 fg/mL to 5 pg/mL in serum. 
Significantly, the investigation about the Debye length opened an approach for further sensing 
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performance improvement. Within the sub-threshold regime of the NWs, the sensor responses 
exhibited about 4 times greater than that in their linear region.  
Studies concentrated on the 2D PANI nanobelts revealed that they have similar rough 
surface and FET behavior to PANI-NWs. This suggested that the 2D PANI nanobelts would 
have comparable performances to 1D PANI-NWs as biosensors. A biosensor system based on 
the PNAI nanobelts was developed. The biosensors exhibited a good specificity and showed a 
linear range for BNP in buffer from 50 to 200 pg/mL. The demonstration of detecting BNP 
levels in human serum further confirmed that the sensor is capable of monitoring BNP in real 
samples. Those findings suggested that this biosensor system has a great potential for clinical use 
in future.  
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1.0  INTRODUCTION 
Biosensors are biomolecular analytical devices that consist of biological recognition elements in 
direct contact with signal transducing elements. Such configuration enables the rapid and 
convenient conversion of the biological recognition events to detectable signals.
1
 With the 
discovery of novel materials and the development of advanced and exquisite micro-/nano-
fabrication tools, such as nanoimprint lithography, electron beam lithography, focused ion beam 
lithography, new routes has been opened up in the field of biosensors in the past decades.
2, 3
 In 
fact, the scientists and researchers have been investigating a multitude of nanosacle biosensors 
and developing new strategies to apply them in ultrasensitive biosensing use.
4, 5
 Examples of 
such biosensors include optical,
6-8
 mechanical,
9, 10
 electrochemical,
11
 and electrical
12
 biosensors. 
Among these biosensors, nano-scale electronic biosensors offer superior advantages, such as 
high sensitive to targets, high resolution for localized detection, compatible with standard large 
scale semiconductor processing, real-time and label-free detection in a nondestructive manner.  
Among many different materials such as semiconductors, metal oxides, and carbon 
nanotube, CPs have shown great promise as a material for sensor application.
13, 14
 Their excellent 
chemical and tunable electrical properties
15
 along with biocompatibility
14-16
 and benign 
electrochemical
17, 18
 or chemical
19
 synthesis route offer several advantages over other materials. 
When integrated as a semiconducting channel in an FET, change in the surface potential caused 
by specific binding of targeted charged analyte to a biorecognition molecule on the surface 
 2 
causes change in the electrical properties of the CPs. However, the use of CPs nanowires for 
biosensing application has been limited due to their incompatibility with traditional micro-
fabrication processes such as lithography due to its possible thermal damage during these 
processes. Hence, it is necessary to develop new fabrication method that allows high throughput 
production of CPs. 
Recently, there has been an increasing interest to integrate advanced biosensors into lab-
on-a-chip systems by introducing microfluidics.
20
 The microfluidic devices have advantage 
including laminar flow, low consumption of costly reagents, minimal handling of hazardous 
materials, short reaction time required for analysis, multiple sample detection in parallel, 
portability, and versatility in design.
21
 Furthermore, as the increasing demand on direct diagnosis 
of blood samples, microfluidic devices are employed to separate the red blood cells to eliminate 
their negative effects. Therefore, developing microfluidic devices with multiple functions would 
be a future trend because it is capable of simplifying the disease diagnosis procedure.  
The early detection and diagnosis is one of the key challenges in cardiac vascular 
diseases control and prevention. Proper and effective clinical treatments are directly linked with 
the success of early detection of  cardiac diseases, which enable to reduce the suffering and cost 
to society associated with the diseases.
22
 B-type natriuretic peptide (BNP) is one of the most 
important cardiac markers for the prediction and diagnosis of heart failure. It is well known that 
when a patient’s heart failure symptoms begin or worsen, the ventricles in the heart secrete BNP, 
causing an elevated level of the marker in the blood. In general, the greater the BNP level in the 
blood, the more severe the condition. The blood BNP concentration under normal conditions is 
~20 pg/mL (6 pM), and it increases to ~2 ng/mL (600 pM) for patients diagnosed with severe 
congestive heart failure. Because this concentration is extremely low in blood, conventional BNP 
 3 
detection techniques thus usually requires expensive instruments such as a photomultiplier or 
excitation light source. Hence sensitive yet expensive, specific yet complicated biosensors are 
highly demanded for fast detection of cardiac diseases in early stage.  
In this chapter, various novel types of high sensitivity nano-sensors categorized by 
different signal detection strategies and the fabrication methods for nanowires are reviewed at 
first. The recent progress on CPs biosensors and miniaturized system for sensors are also 
introduced. Although many new nano-sensor platforms are not fully optimized for manufacturing 
scale up and commercial use, they can provide alternative and irreplaceable diagnostic models. 
The developments of FET biosensors for BNP are presented as well. 
1.1 BIOSENSOR CATEGORIES 
Generally, biosensors are categorized by the types of transducers they used, which convert the 
biochemical interactions into measureable signals. Optical, mechanical, electrochemical, and 
electrical transducers are typically used in biosensors. The transduction efficiency providing by 
the transducers determines many of the analytical characteristics of the biosensors, such as the 
signal stability, reproducibility, detection limit, and in many cases the operational stability and 
selectivity. Different transducers have different detection performance. Hence, different 
biosensors are introduced according to their transducer types in this section.  
 4 
1.1.1  Optical Transducer 
Optical detection principle relies on the unique interactions between nanomaterials and light 
waves. The sensitivity is highly dependent on the optical phenomena being detected. Surface 
plasmon resonance (SPR) is a standard method to monitor the interactions between proteins and 
substrate. It measures the changes in the refractive index of certain types of metal thin films 
when target molecules bind to the surface. When the surface is excited by electromagnetic 
radiation, a coherent oscillation of the surface conduction electrons occurs, which results in 
resonance related to its environment.
23
 Most recent methods allow limits of detection at about 25 
ng/mL and a dynamic range of 2 logs.
6
 However, SPR generally has poor resolution and 
specificity due to bulk solution interference and is difficult to be applied for high throughput 
screening. 
A unique property of SPR occurs when the light interacts with metal particles that are 
smaller than the wavelength of light, like nanoparticles (NPs). The plasmon oscillates locally 
around the NP, known as the localized surface plasmon resonance (LSPR). LSPR sensors are 
sensitive to the size, shape, and environment of metal NPs when their local refractive index 
changes.
8
 The small refractive index changes cause to changes in the extinction spectra of the 
NPs, which can be used to detect biomarker molecular recognition events. LSPR nanosensors 
have been developed into a multi-arrayed biochip with limits of detection of 100 pg/mL.
7
 
However, the development of LSPR nanosensors requires highly uniform nanomaterials to 
produce a narrow LSPR peak. 
Surface-enhanced Raman scattering (SERS) of single molecules is a major detection 
signal of interest in nanosensors because metal or core-shell NPs offer large Raman scattering 
enhancement factors. Important works by Nie and colleagues have explored the SERS field in 
 5 
nanotechnology
24
 as well as for in vivo cancer detection.
25, 26
 However, the Raman scattering 
enhancement effect is dependent on the NP spatial location with respect to the target biomarker 
as well as among each other.  
1.1.2 Mechanical Transducer 
Mechanical detection principle is based on the ultrasensitive detection of extremely small 
mechanical forces on the molecular scale. Nanomechanical sensors can measure transport and 
affinity on the molecular scale as well as forces, mass changes, and displacements. Mass 
resolution of mechanical devices is proportional to the total mass of the device. Thus as 
mechanical sensors turn to the nanoscale, the mass resolution greatly increases. Detection of  
biomolecules in vacuum
27
 and in fluid
28
 has been reported. However, fluid detection, which is an 
ideal condition for biomolecular, is a major obstacle for mechanical nanosensors. The sensitivity 
of the mechanical sensors is greatly reduced by viscous damping in fluid. Suspended cantilever 
resonators are a unique alternative for biomarker detection in fluid, because particles can be 
weighed in real time as they flow through the channel.
28
 
The main device in mechanical nanosensors is the microcantilever. When the analyte 
molecules attach to the immobilized receptors on the surface of a cantilever, the cantilever 
undergoes two responses to measure the displacement. Firstly, the resonance frequency of the 
cantilever shifts due to mass increase or decrease from molecular interaction. Secondly, the 
cantilever bends because of surface stress by the adsorption of the molecules. The bending and 
resonance frequency shifts are measurable using established techniques such as optical beam 
deflection, piezoelectricity and capacitance.
9
 However, detection specificity of microcantilevers 
is very low. 
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Mechanical nanosensors are still limited for clinical applications. The sensitivity and 
selectivity of nanomechanical sensors are dependent on the uniformity of cantilevers and surface 
coating efficiency. Additionally, efficient mechanical sensing requires sensitive instrumentation 
to reduce background noise, which can be costly.
10
 
1.1.3 Electrical Transducer 
Electrical detection is a rapidly developing field with simple and low-cost fabrication techniques. 
Nanosensors by electrical detection, typically nano field-effect transistors (FETs), offer simple, 
direct, and real-time measurements as well as portable capabilities. FET-based electrochemical 
nanosensors utilize nanowires, nanoribbons, and nanotubes to measure the change in 
conductance or resistance induced when the target molecule binds to the receptor. 
29, 4
  
Silicon nanowires are commonly utilized because of their high sensitivit. Lieber and co-
workers in 2001 demonstrated the first use of Si nanowires for direct, sensitive, and real-time 
detection in aqueous solution.
30
 This proof-of-concept Si nanowire FET sensor detected protein 
concentrations as low as 10 pM.
31, 32
 Zheng et al. developed multiplexed electrochemical 
biosensor using Si nanowire field effect devices.
32
 The nanowires are functionalized in  arrays, 
giving about 200 individual sensors, to detect multiple protein markers in undiluted serum. When 
the protein binds to the receptors, the change in the conductance of the specific nanowire is 
detected. Arrays of different types of doped Si nanowires were used in order to distinguish 
protein binding signals from noise. This was the first demonstration of high sensitivity electrical 
nanosensors using Si nanowire arrays. 
Carbon nanomaterials are also being employed for FET nanosensors, specifically carbon 
nanotubes (CNTs).
4
 High sensitivity has been reported using CNTs for DNA detection.
5
 Cai et 
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al. developed an array of CNTs with a molecular imprinted polymer coating on the CNT tips to 
detect proteins using electrochemical impedance spectroscopy (EIS).
11
 A key feature in this 
experiment was the coating of nonconductive polyphenol on the tips of the CNT arrays. The 
protein of interest was initially trapped in the polyphenol and then removed, leaving an imprint 
of the protein on the CNT surface. Because of this confining area, high specificity is achieved. 
Furthermore, this method can be applied for detecting different conformations of proteins. The 
primary detection mechanism is due to the change in permittivity and resistivity in the surface 
materials in response to protein capture. The detection sensitivity is dependent on the impedance, 
which was found to be the highest at the CNT tips because of the faster electron transfer along 
the CNT tip than the sidewall.  
A major limitation of electrochemical biosensors is the inability to detect molecules in 
high salt solutions.
28, 32
 Because electronic detection is based on charge, salt buffers can screen 
the signal and affect the sensitivity of biosensors. For example, nanowire FETs require a salt 
concentration less than 1 mM to prevent screening of the signal. One strategy to overcome this 
salt concentration is to purify the sample upstream of the nanosensors. Stern et al. designed a 
microfluidic purification system and demonstrated its use by detecting two cancer antigens from 
a whole blood sample.
12
 This remarkable detection under complex physiological conditions is 
achieved, not because of the FET device, but by the purification chip. The chip captures various 
types of biomarkers from blood and releases the markers into purified buffer for further electrical 
deteiton. Pre-processing prevents high salt concentrations from interfering with the electronic 
signal. 
Although electrical sensing can take advantage of nanofabrication techniques, additional 
design is necessary to reduce the high salt conditions that biosensors are operated. Nanomaterials 
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can offer high sensitivity thus nanowires, nanoribbons, and nanotubes have been utilized in 
electrical nanosensor. The challenge in electrical nanosensors is that the high salt concentration 
of samples can screen signals and reduce sensitivity. 
1.2 NANOWIRE FABRICATION TECHNIQUES 
Among several of nanoarchitectures, nanowire (NW) is a typical nanostructure that has been 
attracting considerable attention. NWs are one-dimensional structures where the magnitude of 
the material is confined to scales of less than 100 nm in two dimensions. NWs have a vast range 
of potential applications, including electronic, biological, energy, and magnetic devices. NWs 
can be fabricated by either bottom-up or top-down process. In bottom-up processes, 
nanostructures are assembled from their subcomponents in an additive fashion. While top-down 
fabrication strategies use sculpting or etching to carve nanostructures from a bulk material in a 
subtractive fashion. The demand from industry market has motivated research in NWs for the 
past number of decades. The massive competition for a share of the global market has driven the 
expansion of the NW research area, resulting in the evolution of new fabrication techniques, 
innovative processes, and creative advancements in semiconductor NW device design. To date, 
many NW fabricate methods have been well developed, such as optical lithography, e-beam 
lithography, nanoimprint lithography, scanning probe based techniques, tempmate-guided 
growth approaches. In this section, new NW fabrication methods with high yield and high 
density is reviewed, including nanoimprint lithography (NIL), superlattice nanowire pattern 
transfer (SNAP), nanoskiving, nanomolding in capillaries (NAMIC), lithographically patterned 
nanowire electrodeposition (LPNE), and self-assembly methods. 
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1.2.1 Nanoimprint Lithography 
Nanoimprint lithography (NIL) is a process in which a mold is pressed into a deformable 
material to form a pattern. The material is then hardened thus when the mold is removed, the 
topography of the mold is transferred into the material. Its low cost, simplicity, and high fidelity 
make it attractive for a wide range of applications. NIL has been used to pattern structures for 
applications such as magnetic disk memory, biosensor microarrays, and microfluidic channels.
33, 
34
 NIL provides several advantages over alternative optical lithographic techniques. First, NIL is 
a mechanical process thus its resolution is not limited by the diffraction of light as in optical 
photolithography. Secondly, NIL tools do not require complex optics and sophisticated light 
sources, these tools are typically less expensive than optical systems.  
NIL was first demonstrated in 1995.
35
 The process used a silicon stamp to pattern a 
thermoplastic polymer at elevated pressure and temperature. In this technique, a mold is pressed 
into a thermoplastic film while the film is heated above its glass transition temperature. When a 
high pressure applied, the heated viscous material flows and fills the mold. The pattern is then 
cooled, and the mold is removed to leave the pattern on the film. Early demonstrations of this 
technique faithfully transferred 25-nm dot patterns. 
Soft lithography generally refers to imprint techniques with a soft (elastomeric) polymer 
as the template, such as poly(dimethylsiloxane) (PDMS). With soft lithography, a liquid 
precursor is molded against a patterned master and then cured into a soft stamp. These 
techniques are typically used to transfer patterns into organic or functional materials, or to 
transfer an “ink,” such as a self-assembled monolayer (SAM) or biomaterial, onto a substrate. 
Because elastomeric stamp is flexible, soft lithography can also be used to transfer patterns into 
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nonplanar surfaces. A number of permutations of soft lithography using a soft elastomeric stamp 
have been developed.
36-38
 
Step and Flash Imprint Lithography (S-FIL) is a room temperature and low-pressure 
imprint technique. In S-FIL, the imprint material is a photocurable, low-viscosity monomer 
solution and the template is transparent. After the imprint material is dispensed on the substrate, 
the template is brought into close proximity to the substrate, and the imprint material flows to fill 
the template pattern through capillary action without the application of elevated pressure and 
temperature. After exposed to UV light through the transparent template, an inverse replica of 
the template pattern is obtained when the mold is removed. The S-FIL process was developed in 
1999 and was commercialized in fewer than five years.
39
 
For NIL techniques, there are few issues need to be addressed in future. The reductions of 
imprint template and process are needed to improve the uniformity of the imprinted patterns and 
to increase the wafer yield. The resolution of the imprint templates are not yet very high and thus 
limited the resolution of patterns. 
1.2.2 Superlattice Nanowire Pattern Transfer 
The superlattice nanowire pattern transfer method (SNAP)
40
 provides an alternative to other 
nanowire fabrication methods with its own unique advantages. Namely, SNAP can be harnessed 
to produce large arrays of many types of NWs. The SNAP technique resides between NW 
materials growth methods and traditional top-down patterning methods. 
The fabrication process for SNAP Pt NW arrays is illustrated as follows. First, a custom 
grown superlattice is cleaved into 2 mm wide and 5 mm long “masters”. One of the 2 mm wide 
edges is an atomically flat plane. A comblike structure is generated by differentially etching the 
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superlattice using a dilute etch solution. Pt metal is then deposited onto the superlattice edge at 
an angle depending upon the pitch of the superlattice. Those Pt NWs are then transferred as an 
ink by gently dropping them onto a substrate coated with a thin layer of heat-curable epoxy. The 
epoxy coats the thin film from which the final NWs will emerge. This dropping step may be 
controlled using a custom-built chuck. The epoxy formulation is critical for ensuring a high 
process yield. The epoxy/master is heat cured, and the metals NWs are released from the 
superlattice using a wet chemical etch, thus forming an array of Pt NWs. 
SNAP NWs have many advantages. First they inherit their own properties from the thin 
film substrate from which they are made. This means, for example, that p-type and n-type Si 
NWs can be readily prepared side by side and that p-n diodes are readily obtained. Some NW 
materials are uniquely available using SNAP, including insulators and certain metals. Second, 
the width and pitch of SNAP NW arrays are translated from the precisely controlled film 
thicknesses and spacings of the superlattice template. Third, SNAP NWs may be a millimeter 
long or longer. Long NWs can exhibit unique physics, and they enable the construction of 
relatively large scale NW circuits. 
1.2.3 Nanoskiving 
“Nanoskiving” is the name that the research group of G. Whitesides given to a technique for the 
fabrication of nanostructures that combines the deposition of thin films on flat or patterned 
polymeric substrate using physical vapor methods with sectioning by an ultramicrotome.
41
 The 
first step utilizes an epoxy substrate obtained by curing an epoxy pre-polymer against a flat or 
patterned PDMS stamp.
42
 Current deposition techniques make it possible to form films with 
nanometer thickness on the surface of this epoxy. They embed the resulting structure in more 
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epoxy and generate an epoxy block containing an embedded thin film. An ultramicrotome 
sections this block to produce slabs with thickness about 30 nm. After sectioning, the slabs 
typically float on the surface of water filling the sample-collecting reservoir of the microtome. 
The epoxy sections can be transferred onto a solid substrate, and the epoxy is removed by 
oxygen plasma leaving freestanding nanostructures. The dimensions of the structures are 
determined by the topography of the substrate, the thickness of the deposited film, and the 
thickness of the epoxy slab generated by sectioning. 
Nanoskiving, on the other hand, still have many issues. Many important procedures in 
nanoskiving, especially sample mounting and aligning, are currently done exclusively by hand, 
thus the generation of high-quality sections requires an experienced microtome user. The 
development of an automated microtome instrument would be required to eliminate the influence 
of the user on the quality of the section. The sectioning procedure can cause to artifacts and 
defects in the nanostructures. Brittle materials, such as SiO2, tend to crack and form small 
segments during sectioning. The sample can compress during sectioning, causing deformation of 
the nanostructures and variation of the true thickness of individual nanostructures.
43
  
1.2.4 Others 
Penner et al. have recently described a new method for patterning electrodeposited metal 
nanowires on glass using photolithography.
44
 That method, called lithographically patterned 
nanowire electrodeposition (LPNE), involves the photolithographic fabrication of a sacrificial 
template on the glass surface composed of photoresist and a metal film. They demonstrated that 
LPNE provides the means for patterning noble metal nanowires with lateral dimensions down to 
18 nm on glass surfaces.
45
 These nanowires can be 1 cm or more in total length. In their report, 
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LPNE is used to produce nanowires of gold, platinum, and palladium on various films. 
Moreover, LPNE method enables the fabrication of potentially useful nanowire architectures 
including crossed nanowire networks and nanorod arrays. 
Rotello et al. reported the use of nanomolding in capillaries (NAMIC) to pattern small 
gold nanoparticles into stable 1D NP arrays.
46, 47
 The covalent linking of Au NPs on the substrate 
provides 1D arrays having a uniform layer of NPs on the surface with high stability to organic 
solvents and water. Additionally, owing to the robust chemical immobilization, the patterned Au 
NPs can be further modified and potentially can be used for biosensor applications. 
Self-assembly has been the subject of intense research as a result of the ability of these 
macromolecules to create dense arrays.
46
 The self-assembly process is facilitated by various 
annealing techniques.
48, 49
 Harris et al. demonstrated a simple and efficient method for doubling 
the density of line structures templated by block copolymers (BCP) self assembly. In annealed 
BCP films containing two layers of parallel horizontal cylinders. Cylinders of the upper layer 
form over the interstices of the cylinders in the underlying lower laye.
50
 While each layer of 
cylinders has a pitch of L, if the matrix between the cylinders is removed, the three-dimensional 
assembly of parallel cylinders collapses to form an array of parallel cylinders with half the 
original pitch (L/2).
51
 
Yun and co-workers
52
 demonstrated a versatile concept for fabricating single polymer 
and metal nanowires in 2004. They showed that single nanowires could be electrodeposited 
between lithographically patterned gold electrodes on a wafer surface. The application of a 
controlled current between these two electrodes in an aqueous solution at one of these electrodes 
initiates the growth of the nanowire in the direction of the second electrode across the gap. 
Nanowires with minimum widths in the 70 nm range and low contact resistance were achieved in 
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their work. A recent innovation in the nanowire growth process is the addition of a third 
electrical contact to this apparatus.
53
 This third contact is obtained by patterning the two gold 
electrodes on a silicon wafer covered with a thin gate oxide. The application of a gate voltage to 
the silicon back gate during the electrodeposition modifies the morphology of the nascent 
nanowire during growth, producing a higher degree of wire width uniformity and the possibility 
to reproducibly obtain nanowires with diameters less than 50 nm. 
1.3 CONDUCTING POLYMERS    
The emergence of a new class of materials called the CPs opens up exciting new applications in 
several fields including bioelectronics. CPs contain monomers capable of acquiring positive or a 
negative charges through oxidation or reduction which in turn contributes to the electrical 
conductivity in CPs. Some examples of CPs are polyacetylene (PA), polypyrrole (PPy), 
polythiophene (PT) and polyaniline (PANI). CPs also have highly flexible chemical structure 
that can be modified to acquire desired electronic and mechanical properties. Since the CPs have 
the ability to efficiently transfer electrons produced by biochemical reactions, they have been 
used extensively in biosensors in the form of transducer. They are also known to be compatible 
with biological molecules in neutral aqueous solution. For the same reason, CPs have attracted 
much attention as a suitable matrix for entrapment of biomolecules. In this section, the state-of-
art of CPs based sensors developed for biomedical applications are reviewed.  
Clark and Lyons
54
 developed the first biosensor device almost 50 years ago by 
integrating enzyme and glucose oxidase to an electrode. Many efforts have been made in the 
development of biosensors for use in diagnostic detection in past decades. Moreover, recent 
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advances in lab-on-chip devices have stimulated demand for portable, highly sensitive, real-time, 
and precise analytical tools for easy detecting analytes such as glucose, cholesterol, antibodies, 
nucleic acids, hormones, drugs, viruses, and so on. 
Since the discovery of metallic polymer,
55
 CPs have been extensively used as transducers 
in biosensors to measure and amplify signals.
56
 Both CPs and CPs-nanocomposite materials have 
been used as transducers. Some of the most commonly used CPs for development of different 
types of electrochemical biosensors are: PANI, PPy, and PT. Their properties adjustable 
transport properties, and chemical specificities makes conducting polymers attractive candidates 
for applications in electrochemical sensing.
57
 
Initial research efforts on biosensors predominantly consist of enzymatic biosensors. 
Another class of sensors known as affinity biosensors (immunosensors, DNA sensors, and 
receptor sensors) have also become increasingly popular due to their potential to sense 
biomolecules at extremely low concentrations.
56
 Consequently, the immobilization of bioactive 
molecules in or on the transducer becomes to be a key aspect for obtaining highly efficient 
affinity biosensors.
58
 The modification of biomolecules can be achieved by non-covalent 
interaction and covalent linkages. To date, both covalent and non-covalent modifications of the 
biomolecules have been extensively explored and reviewed in detail.
56, 59, 60
  
Based on the mechanism used for signal detection and measurement, biosensors can be 
divided into several categories: amperometric, potentiometric, conductometric, optical, and 
calorimetric. The most common types of transducers are amperometric and potentiometric.  
Amperometric biosensors measure the current produced by oxidation or reduction processes 
happening in the bio-recognition layer. Investigations into amperometric biosensors based on 
polymeric nanotubes
61
 and nanofibers
62
 have opened up new frontiers for electrochemical 
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biosensors. For example, Ekanayake et al.
61
 developed PPy nanotube arrays enzymatic biosensor 
for sensing glucose. PPy was deposited on a platinum plated nano-porous alumina substrate 
which enhanced adsorption of the enzyme-glucose oxidase and provided an increased surface 
area for the sensing reaction. Potentiometric biosensors use ion-selective electrodes or gas 
sensing electrodes as physical transducers to measure electric potential due to concentration 
changes of analytes-of-interest. For example, urea is detected by ureases via the production of 
NH3 which, in turn, interacts with PPy to produce an electric potential. A number of pH-sensitive 
polymers have been synthesized for potentiometric detection of analytes or ions-of-interest in 
solution.
63
 In short, CP-based biosensors are likely to address the issues of biocompatibility for 
continuous monitoring of biological metabolites and drug dosages, and the possibility of in vivo 
sensing.
64
 
1.4 MINIATURIZED SYSTEM 
Biosensors are more preferred as a clinical diagnostic tool than other methods partially because 
of real-time measurement, rapid diagnosis, multi-target analyses, and reduced costs.
65
 As 
advances in molecular biology have led to our better understanding of potential disease-related 
protein biomarkers, biosensors became a promising technology for early diagnosis.
66-68
 Recently, 
there has been an increasing interest to integrate advanced biosensors into lab-on-a-chip systems 
by introducing microfluidics.
20
 The lab-on-chip systems have advantages including low 
consumption of costly reagents, minimal handling of hazardous materials, short reaction time 
required for analysis, multiple sample detection in parallel, portability, and versatility in design.
21
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The miniaturized systems are also considered as powerful tools for whole blood 
separation in clinical applications. Recent studies have found that the separation of plasma from 
blood cells is often critical to eliminate the interference of blood cells (primarily red blood cells), 
thereby increasing assay sensitivity and reliability. The existence of red blood cells in human 
blood is a important issue for the performance of most of the biosensors, thus the separation of 
whole blood within the miniaturized systems is necessary for clinical diagnosis. Many efforts 
have been made in the studies of utilizing miniaturized systems for blood separation. Separation 
of plasma on microfluidic devices has been demonstrated using different techniques and 
platforms, including employing filter trench,
69, 70
 using the lab-on-a-CD platform,
71
 and 
exploiting the Zweifach-Fung effect.
72
 
Lee et al. reported a two-step, self-contained, and self-powered integrated microfluidic 
blood analysis system (SIMBAS).
70
 The system integrates whole-blood plasma separation from 
red and white blood cells with multiple immunoassays. They utilize the physical properties of 
PDMS in combination with the microfluidic channel resistance to propel fluid into and through 
the channels. After removing the device from its vacuum pouch or container, the user simply 
dispenses the sample droplets onto the multiple inlets of the device and degas-driven flow 
propels the sample into the device. As the whole-blood passes over the filter trench, blood cells 
sediment gravitationally thus are filtered while plasma flows into the channel. Finally, plasma-
based proteins are detected as the plasma flows across the biomarker detection zone.  
Centrifugal microfluidic platforms are of particular interest for assay integration as their 
artificial gravity field intrinsically implements a pumping force. Haeberle et al. present a novel 
decanting process for the extraction of plasma from the cellular constituents.
71
 The blood sample 
defined between hydrophobic stop and overflow channel flows from the metering chamber via 
 18 
the drain channel into the decant structure. A shock interface separating plasma from the cellular 
pellet builds out in all parts of the network and proceeds radially outwards at a certain speed. The 
filling height of the decant chamber rises at counter-current speed before the plasma overflows 
into the plasma collection chamber. The speed of the filling height in the cell reservoir is 
adjusted by the hydrodynamic resistance of the drain channel, therefore, only purified plasma 
advances to the plasma reservoir. 
Aran et al. have developed a high throughput membrane-based cross-flow microfiltration 
microdevice to extract 100% cell-free plasma from blood over a wide range of hematocrit 
concentrations.
69
 A membrane based filtration approach was used in this project. The mass flux 
between microfluidic channels can be precisely controlled by incorporating membranes with 
various pore sizes in between the channels. The separation membrane is directly bonded as a 
laminated structure with aligned microfluidic channels so it can operate at high pressures over an 
extended period of operation (over 4 h). 
Yang et al. developed a microfluidic device for continuous, real time blood plasma 
separation for the application of the online monitoring of inflammatory responses.
72
 In their 
report, plasma separation is accomplished by a simple microfluidic network based on the 
Zweifach-Fung effect. When erythrocytes (red blood cells) flow through a bifurcating region of a 
capillary blood vessel, they have a tendency to travel into the daughter vessel which has the 
higher flow rate leaving very few cells flowing into the lower flow rate vessel. The critical flow 
rate ratio between the daughter vessels for this cell separation is approximately 2.5 when the cell-
to-vessel diameter ratio is of the order of one. The reason for this phenomenon is that cells are 
drawn into the higher flow rate vessel because they are subjected to a higher pressure gradient. In 
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addition, the asymmetric distribution of shear forces on the surface of the cell produces a torque 
on the cell, pulling it towards the faster flow rate vessel. 
 To become useful diagnostics tools in POC settings, microfluidic systems would require 
further improvement by integrating the sample preparation, possibly including on-board reagent 
storage, incorporation of multiplexed biomarker detection on a single device, and minimization 
of the number of user steps required to perform an assay, without compromising device 
functionality or assay sensitivity. Some of the most important improvements will include 
simplifying the microfluidic design, reducing the amount of external support equipment required,  
the number of on-chip components (such as valves), the number of fabrication steps, and the 
range of different materials used. These steps would reduce the cost of manufacture while 
increasing device reliability. 
1.5 BIOSENSOR FOR BNP BIOMARKER 
Nowadays, BNP has become to one of the most important cardiac markers for the 
prediction and diagnosis of heart failure since the first discovery of BNP in 1988. In general, the 
measurement of BNP concentration in blood needs huge and expensive equipment such an 
excitation light source or photomultiplier. Recently, Yukari et al.
73
 reported a highly sensitive 
and low-cost immunoassay method for BNP measurement, but the detection limit for BNP (20-
40 pg/mL) was still insufficient to detect the basal level of blood BNP. A year later, Osamu et 
al.
74
 developed a novel miniaturized enzyme immunosensor for BNP detection using 
microfluidics combined with a portable SPR system. The sensor can determine BNP with high 
sensitivity. In addition, the detection limit and assay time are greatly improved. A detectable 
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concentration range of 5 pg/mL-100 ng/mL by monitoring the SPR angle shift was achieved, 
which covers the required detection range for the BNP concentrations found in blood. 
In 2008, a two-dimensional cross-linked polysiloxane Langmuir-Blodgett film has been 
reported to be useful as a permselective layers in amperometric BNP biosensors.
75
 The use of 
monolayers of proteins, nucleic acid bases, redox-active molecules, and synthetic polymers for 
the construction of biosensors. The chemisorption-desorption process of thiol monolayers was 
utilized for the measurement of cardiac biomarker. The dynamic range for BNP was found from 
40 to 200 pg/mL and the total assay time was 70 min. 
A silicon nanosensor technology based on electrical impedance measurements has been 
developed for the detection of BNP.
76
 Nanoporous alumina was integrated with silicon 
microelectronics to generate robust ultra-porous devices for rapid proteomic diagnostics of 
clinical samples. The nanosensor miniaturizes the high-density, low-volume multiwell plate 
concept. This technology has the capability to achieve near real-time detection a dynamic range 
of 1 ag/mL to 10 μg/mL for BNP.  
Despite very sensitive biosensors were built for the BNP detection, it is suggested to 
monitor the BNP biomarker on a regular basis in blood or serum samples for those at an elevated 
risk of heart failure so that a negative event could be detected even before the patient actually 
started feeling badly. While these were few reports about the BNP measurement in blood or 
serum. Hence for this purpose, biosensors that can detect trace level of BNP in real blood or 
serum sample with fast response, low cost, and high reliability are highly desired. 
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2.0  ELECTROCHEMICAL DEPOSITED CONDUCTING POLYMER BIOSENSOR 
2.1 INTRODUCTION 
Advanced biosensors based on nanostructured materials for point of care diagnosis are in high 
demand in recent years. Devices made from conducting polymer nanowires,
14, 77
 semiconductor 
nanowires,
32, 78, 79
 and carbon nanotubes
80-82
 have been used for the real-time detection of viruses, 
small molecules, and proteins because of their extraordinary electrical, mechanical, and thermal 
properties.
32
 Although single-nanowire-based biosensors have achieved outstanding detection 
performances, there is still much room for further improvement in terms of the detection rate, 
sample volume consumption, specificity, fabrication complexity, and cost.  
One strategy to significantly improve biosensors’ overall performances is to incorporate 
them into microfluidics. Microfluidic devices have several advantages such as the reduced 
consumption of samples and reagents, comparatively fast and more sensitive reactions, and 
intrinsic compatibility.
83
 So far, reversible sealing methods including mechanical fixation
84
 and 
adhesive tape sealing
85
 have been used to integrate pre-functionalized biosensor chips with 
microfluidic systems. However, reversible seals provided by simple van der Waals contact can 
only withstand fluid pressures up to ~5 psi. As a result, combining microfluidic systems with 
pre-functionalized single nanowire biosensors via irreversible sealing still poses a challenge. 
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Another strategy to improve the functionality of biosensors is to use aptamers as 
detection probes because they are highly specific to their targets. Antibodies have been 
extensively used as probes to detect targets such as prostate-specific antigen (PSA) and 
immunoglobulin (IgG).
32, 86, 87
 Nevertheless, those probes can be easily denatured under severe 
conditions, and thus limit their use in practical applications. As an alternative probe, aptamers 
are more favorable because their target specificity and affinity are often superior to those of 
antibodies.
82
 Aptamers are artificial oligonucleotides (RNA or DNA) that can be isolated from 
combinatorial nucleic acid libraries using in vitro selection methods.
88
 As a result, aptamers can 
be synthesized at relatively low cost, and be easily engineered when necessary. When subjected 
to certain severe conditions, aptamers are stable or undergo reversible conformational change; 
under the same conditons proteins are irreversibly denatured. Because of these advantages, 
aptamers have been investigated and touted as novel probes for protein sensing with high 
specificity.
89
  
In this chapter, we present aptasensors based on aptamers incorporated polypyrrole 
nanowires (PPy-NWs) for rapid and label-free detection of proteins within microfluidic systems. 
Immunoglobulin E (IgE) is used in this work to demostrate the rapid response and high 
specificity of the aptasensor. According to this principle, another aptasenor is developed to detect 
Mucin 1 (MUC1), which are known to be overexpressed in almost of all human epithelial cell 
adenocarcinomas, including lung,
90
 prostate,
91
 breast,
92
 and ovarian.
93
 The expression of MUC1 
increases so much in many cases thus large amounts of the protein can be found in blood,
94
 
which makes the detection of MUC1 potentially useful for cancer diagnosis.  
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2.2 EXPERIMENTAL 
2.2.1 Chemicals 
Pyrrole (≥99.5%), NaCl, and bovine serum albumin (BSA) were purchased from Sigma Aldrich. 
IgE protein was obtained from Athens Research & Technology, and MUC1 protein was 
purchased from peptide synthesis facility of the University of Pittsburgh. Aptamers for IgE and 
MUC1 were synthesized by Integrated DNA Technologies (IDT; Coralville, IA, USA). 
Phosphate buffer solution (PBS, pH 7.4) was used to prepare the BSA and IgE solutions with 
different concentrations.  
2.2.2 Preparation of Aptamer Incorporated PPy-NW 
The aptamers incorporated PPy-NWs were electrochemically grown in patterned 
polymethylmethacrylate (PMMA) nanochannels between two Au electrodes on a wafer chip 
cutted from a whole 4 inch wafer (figure 2.1). An illustration of the preparation of aptamer 
incorporated PPy-NW is schematically shown in figure 2.2. A drop of electrolyte solution 
consisting of pyrrole monomer (5 mM), NaCl (10 mM), and aptamer (2 μM) was placed on the 
nanochannel between the electrodes. Then a constant current was applied between the Au 
electrode pair and the corresponding potential across the electrodes was monitored during the 
growth process. When the potential drops close to zero (normally around 500 μV), the nanowire 
is grown and connected between the electrodes (see figure 2.3a and b). After the nanowire 
preparation, the samples were rinsed with deionized water three times. The nanowires were then 
examined using fluorescence microscopy. 
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Figure 2.1. A whole 4 inch wafer containing 69 small chips. 
 
  
Figure 2.2. (a) Schematic illustration of the aptamer incorporation during the PPy-NW synthesis. (b) 
Scanning electron microscopy image of an aptamer incorporated PPy-NW grown between the gold electrodes pair. 
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Figure 2.3. (a) Chronoamperometric curve of the electrochemical deposition of aptamer dopted PPy 
nanowire. The potential between the electrodes pair drops close to zero once the nanowire is grown. Typically the 
nanowire growth can be completed in 20 seconds. (b) The I-V curve of an aptamer doped PPy nanowire with a 
resistance measured as 715 ohms. 
2.2.3 Integration of Microfluidic Aptasensor 
A poly(dimethysiloxane) (PDMS) microfluidic structure with six channels was fabricated 
through a replica molding process with a SU8 master. PDMS was selected for this work because 
it is a biocompatible material.
95
 The PDMS replica was treated with oxygen plasma for 1 minute, 
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and irreversibly sealed on the chip containing the aptasensors. A hole was punched through the 
PDMS on both ends of each microchannel and tubings were inserted into these holes to complete 
the microfluidic aptasensor.  
2.2.4 Conductance Measurment 
The real-time IgE detections in 10 mM phosphate salt buffer (PBS, pH=7.4) solution were 
performed at room temperature using the aptasensor with and without the microfluidic system. 
The PBS solution was placed on the aptasensor and then a constant current (100 uA) was applied 
across the nanowire. The conductance of the nanowire was monitored. When the conductance of 
the aptasensor stabilized in the PBS solution, the non-specific protein bovine serum albumin 
(BSA) solution was added, followed by several IgE solutions with different concentrations. The 
same procedures were performed for the IgE and MUC1 detections using aptasensors within the 
fabricated microfluidic system (figure 2.4) in this work.  
 
Figure 2.4. The microfluidic system. Two syringe pumps are used to flow the PBS and target solution. The 
solutions are injected in to the microfluidic channel through tubing. 
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2.3 RESULTS AND DISSCUSION 
2.3.1 Fluorescence 
To confirm that the aptamers were successfully incorporated into the PPy-NWs, fluorescent-dye-
labeled (Fluorescein amidite, FAM) aptamers were used during the electrochemical deposition. 
The physically adsorbed aptamers were removed by rinsing the nanowires with deionized water 
for three times. As shown in figure 2.5, the PPy-NW was connected with the gold electrodes by 
two thick ends that ensured good contact. The fluorescence microscopy image (figure 2.5b) 
showed that the dye molecules were successfully entrapped in the PPy-NW. The nanowire 
exhibited green emission (bright region) with uniform distribution over its surface, which 
indicates that the aptamers were incorporated into the PPy-NW. Remarkably, clear fluorescence 
can be observed from most of the PPy-NWs incorporated with fluorescence-labeled aptamers, 
suggesting the excellent reproducibility of this aptamer incorporation approach. 
 
 
Figure 2.5. Optical (a) and fluorescence microscopy (b) images of an aptamer incorporated PPy-NW 
grown between the gold electrodes pair. The fluorescence image confirms that the aptamers have been successfully 
incorporated into the PPy-NW. Scale bars are 5.0 um. 
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2.3.2 IgE and MUC1 Detection 
The normalized real-time response [(G-G0)/G0] of the aptasensors and the control sample are 
shown in figure 2.6a. For the IgE aptasensor (without microfludic system), non-appreciable 
changes in the curve were found upon the addition of BSA (1.5 uM). In contrast, significant 
conductance increases were observed in the curve after the addition of IgE solutions. This 
observation indicates that the aptasensor has a good specificity to IgE protein. On the other hand, 
the negative control of PPy-NW (without aptamers) only showed negligible changes 
corresponding to BSA and IgE solutions, which further confirms the excellent specificity of the 
aptasensor. Stepwise conductance increases were shown in the same figure upon the addition of 
IgE solutions on this aptasensor. After the addition of a 0.1 nM IgE solution, the conductance of 
the aptasensor increased rapidly and then stabilized slowly within 200 seconds. As the IgE 
concentration was increased to 1 nM, 10 nM, 100 nM, and 1 μM, consistent increases in the 
aptasensor conductance of 1.10%, 1.46%, 1.69%, and 1.77% were observed respectively, using 
the baseline as a reference. This response increase is attributed to an increase in the negative 
charge density on the PPy-NW resulting from the specific binding event.
77
 The PBS solution of 
pH 7.4 caused the IgE protein to be negatively charged because it is higher than the isoelectric 
point of the IgE protein (pI=5.2–5.8). Therefore, the specific binding of the aptamer and the 
negatively charged IgE protein would result in an increased negative charge density on the PPy-
NW, which could lead to the conductance increase. 
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Figure 2.6. (a) Normalized real-time response of aptasensor, microfluidic aptasensor, and PPy-NW to BSA 
and IgE solutions. Arrows indicate the points of injecting protein solution [Aptasebsor and PPy-NW: 1&7. 1.5 μM 
BSA; 2-6. 0.1, 1, 10, 100, 1000 nM IgE. Microfluidic aptasensor: 1&7. 1.5 μM BSA; 2-6. 0.01, 0.1, 1, 10, 100 nM 
IgE.]. (b) Normalized real-time detection of cancer biomarker MUC1 using MUC1 specific aptamer incorpoarted 
PPy-NW sensor within the microfluidic system. 
The obtained detection results (figure 2.6a dot-line; without microfluidic system) indicate 
that the aptasensor was almost saturated at 1 μM. Therefore, the IgE concentration was optimized 
from 0.01 to 100 nM for the microfluidic aptasensor. As shown in figure 2.6a, stepwise 
responses were also observed. The conductance of this microfluidic aptasensor changed rapidly 
and stabilized quickly (~20 s) after the IgE solutions were injected. A similarly enhanced 
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response was reported previously and attributed to the enhanced effects of diffusion and mass 
transport of the biomarkers within the microchannel.
83
 From baseline, the conductance of this 
microfluidic aptasensor increased consistently from 0.32% to 1.26% as the IgE concentration 
increased from 0.01 to 100 nM. The signal-to-noise ratio was 3.6:1 at the lowest IgE 
concentration. So far, the reported detection limits for IgE are about 0.01 nM and 10 nM using 
conventional surface plasma resonance (SPR) measurements
96
 and quartz crystal microbalance 
(QCM) biosensors
97
 respectively, which are the same or higher than the value achieved in this 
work. However, rather than optical techniques, electrical detection possesses advantages 
including not only the portability, but also the independence from the optical path length, sample 
turbidity, extremely low cost, and low power requirements. 
Another microfluidic aptasensor was then fabricated for the detection of cancer 
biomarker MUC1 using MUC1-specific-aptamer as the detection probe. As shown in figure 2.6b, 
time-dependent conducatance measurements recorded on the microfluidic aptasensor exhibited 
no change in conductance upon addition of 1.5 uM BSA. However, a significant increase in the 
conductance was observed after the injection of 2.66 nM MUC1 solution, demostrating the high 
specificity of this microfluidic aptasensor. As the concentrations of MUC1 were subsequently 
increased to 13.3 nM and 66.5 nM, the condunctance of the microfluidic aptasensor was 
increased to 2.25% and 2.8% respectively. As far as we are aware, the lowest detection 
concentration for the most popularly used CA 15-3 assay, which is a currently commercially 
available ELISA kit for the detection of MUC1, is estimated to be 800 nM of MUC1.
98
 The 
results showed here indicates that the aptamer-based detection method within the microfluidic 
system is not only rapid but also sensitive, with a very low detection concentration of 2.66 nM 
MUC1.  
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2.3.3 Sensitivity 
Figure 2.7a shows the sensitivities of the aptasensor and microfluidics aptasensor obtained from 
three NWs for each case. The aptasensor was very sensitive exhibiting 0.79±0.04% change in 
conductance even at the IgE concentration of 0.1 nM (20 ng/mL), which is about 2 times greater 
than that obtained from an aptamer-doped PPy film.
89
 On the other hand, the microfluidic 
aptasensor showed responses to IgE solutions within the range from 0.01 nM (2 ng/mL) to 100 
nM (20 μg/mL), showing a 0.57±0.07% change in conductance at the IgE concentration of 0.1 
nM. Despite the small decrease in sensitivity of the microfluidic aptasensor, the reproducible 
responses of the microfluidic aptasensor remain within distinguishable level. Clearly, both high 
sensitivity and fast response are important for biosensors. For this microfluidic aptasensor, the 
sensitivity was decreased probably because of the degradation the biomolecules during the 
microfluidic device integration process (i.e. the sealing of PDMS replica on the chip). However, 
using microfluidic system in this experiment showed great improvement on the response time. 
Optimizing the microfluidic device integration process could increase the sensitivity of the 
microfluidic aptasensor in future.  
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Figure 2.7. (a) The sensitivity of the aptasensor with and without microfluidic system as a function of IgE 
concentration, data were collected from three aptasensors for each case. (b) Regeneration of the aptasensor upon 
treatment with 0.01 M HCl. The data are collected with IgE concentration of 0.1 nM. 
2.3.4 Reusablity 
The possibility of reusing a sensor several times with or without a regeneration step is highly 
desirable, but typically difficult to achieve. For example, the dissociation of antibody-antigen 
complexes can usually be achieved by treating with acid solution. However, the antibodies are 
irreversibly damaged to some extent.
99
 In contrast, the aptamers are almost capable of reversible 
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regeneration. The reversible conformational change of the anti-IgE aptamer was investigated 
with acid treatment. The used aptasensor was incubated in 1 μL of 0.01 M hydrochloric acid for 
15 min and followed by thorough washing with 10 mM PBS buffer. As shown in figure 2.7b, the 
as-prepared aptasensor showed 0.91% response to the 0.1 nM IgE solution and the incubation 
restored the aptasensor functionality for up to three repeated measurements with no significant 
loss of sensitivity. This result indicates the good reusability of this aptasensor.  
2.4 CONCLUSIONS 
In conclusion, we have successfully demonstrated the Ppy-NW-based microfluidic aptasensor for 
rapid and real-time detection of IgE and MUC1 with high sensitivity and specificity. The one-
step incorporation of biomolecules into the dimension-controllable conducting polymer nanowire 
eliminates post-synthesis surface modification and simplifies the device fabrication process. The 
fluorescence microscopic image confirmed the successful incorporation of the aptamers. This 
microfluidic aptasensor provided fast response and stabilization times. Furthermore, the 
functionality of this aptasensor can be simply restored by acid treatment with no majoy change in 
sensitivity. Importantly, the proposed method for aptasensor fabrication can be easily adapted for 
the development of various aptasensors based on different conducting polymers and different 
aptamers for specific targets. A microfluidic aptasensor for the detection of MUC1 was 
accordingly developed. This aptasensor acheived a very low detection concentration of 2.66 nM 
MUC1 in this research. These results indicates the possibility for developing rapid and sensitive 
biosensor devices for the detection of cancer biomarkers. 
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3.0  BIO-SHIELDING MASK FOR NANOWIRE-BASED MICROFLUIDIC 
BIOSENSOR  
3.1 INTRODUCTION 
Microfluidic devices are of considerable interest for biosensors because of several advantages 
that they provide: reduced consumption of sample, protection of the sensor by the microchannels 
from environment, and comparatively fast and more sensitive reactions.
83
 Consequently, 
microfluidic devices have been used in various areas, such as biological and chemical 
analysis,
100
 point-of-care testing,
101
 clinical analysis,
102
 and medical diagnosis.
103
 Numerous 
examples found in the current literatures include the detection of pathogens using a microfluidic 
device,
104
 the quantification of nucleic acid sequences by an electrochemical microfluidic 
biosensor,
103
 and multiple ions analysis with a biosensor array microfluidic device.
105
 While 
most microfluidic biosensors use fluorescence
100, 106, 107
 or surface plasmon resonance
74, 108, 109
 
for signal generation, utilizing electrical detection systems offer the advantages of simplicity and 
high sensitivity.
103, 105
  
Poly(dimethylsiloxane) (PDMS) based microfluidics are most favorable for microfluidic 
devices
95, 110
 because the microfabrication in polymers is easy and relatively cheap. The basic 
microfabrication process of a PDMS based fluidic chip involves the patterning of the channel 
structure, the sealing of the open channel, and sensor fabrication.
111, 112
 Typically, elastic PDMS 
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is used to replicate microchannels using inverse microfluidic structures from the mold (or 
master) which can be obtained by photolithography. It is easy to release the PDMS replica from 
the mold without damaging itself or the mold because of its low surface free energy and 
elasticity. Finally, enclosed microchannels can be obtained by sealing the PDMS replica to a flat 
surface.  
PDMS can reversibly or irreversibly seal to itself or to other surfaces without distorting 
its shape.
113, 114
 Usually, reversible seals provided by simple van der Waals contact can withstand 
fluid pressures up to ~5 psi.
114
 To obtain seals that can hold higher pressures, oxygen (O2) 
plasma treatment is usually employed. However, most microfluidic biosensor devices that use 
irreversible sealing require surface modification after device assembly because O2 plasma 
treatment can damage the detection elements. In particular, it is necessary to prevent damages on 
the biofunctionalized nanomaterial-based sensors for the integration of microfluidic devices 
using plasma treatment. Other methods such as mechanical fixation
104
 and UV-curable 
adhesives
95
 have been applied to avoid the deactivation of biomolecules immobilized on these 
nanomaterial-based sensors. But these reversible sealings are not able to withstand high fluid 
pressures thus limiting their applications. As a result, assembling a PDMS replica to a pre-
functionalized chip via irreversible sealing is an important challenge for nanomaterial-based 
microfluidic biosensors. 
In this chapter, we present a low-cost and facile approach that can protect the pre-
functionalized biosensor throughout the irreversible sealing process. Inspired by the 
nanofabrication approaches that utilize masks to make patterns on substrates,
115, 116
 we employ a 
shadow mask to cover the substrate and prevent the damage to biomolecules that would typically 
occur during O2 plasma treatment. The effects of shadow mask on the electrical measurement, 
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the fluorescence intensity, and the detection ability of as-prepared and O2 plasma treated 
nanowire (NW) biosensor are evaluated. In addition, an integrated microfluidic biosensor device 
is demonstrated, which confirms our assumption that the utilization of shadow mask can protect 
the pre-functionalized sensor during the plasma treatment. 
3.2 EXPERIMENTAL  
3.2.1 Chemicals 
Pyrrole, aniline, NaCl, bovine serum albumin (BSA), 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC), and N-Hydroxysuccinimde (NHS) were purchased from Sigma Aldrich. 
Fluorescent-dye-labeled aptamer (5’-GGGGCACGTTTATCCGTCCCTCCTAGTGGCGTGCC- 
CC-3’) was synthesized by Integrated DNA Technologies. Immunoglobulin E (IgE) was 
provided by Athens Research & Technology. Goat anti-rabbit immunoglobulin G (IgG) 
monoclonal antibodies (mAbs) and IgG protein were obtained from Invitrogen. Phosphate buffer 
solution (PBS, pH 7.4) was used to prepare the BSA, IgE, EDC, NHS, and IgE solutions with 
different concentrations. 
3.2.2 Nanowire Preparation and Functionalization 
Two different kinds of NWs were fabricated in this work for comparison. One was polypyrrole 
NWs that incorporated with aptamers (aptamer-PPy) during the NWs growth, and another one 
was polyanniline (PANI) NWs that surface modified by mAbs after the growth. The details of 
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the fabrication of addressable single polymer NW can be found in our previous reports.
52, 53
 Pre-
patterned polymethylmethacrylate (PMMA) nanochannels between the electrodes pairs were 
used to guide the growth of Aptamer-PPy NWs while a constant current were applied using a 
semiconductor analyzer (Agilent B1500A). The growth of the NW was monitored by the 
potential between the electrode pair. The NW growth is completed when the potential decreases 
to ~500 μV. The electrolyte solution consisting of pyrrole monomer (5 mM), NaCl (10 mM), and 
aptamer (2 μM) was used to prepare aptamer-PPy NWs. The obtained samples were rinsed with 
deionized water three times after the NWs preparation. 
3.2.3 Oxygen Plasma Treatment and Microfluidic Integration 
A PDMS microfluidic structure with six channels was fabricated through a replica molding 
process with a SU8 master (silicon elastomer base and curing reagent were mixed in a 10:1 ratio, 
degassed for 1 h, and then cured at 85℃ for 3 hrs). By hollowing out an aluminum plate, six 
cantilevers were created along the top and bottom sides of the shadow mask. Each cantilever can 
cover an area with a length of 6.2 mm and a width of 0.8 mm that is enough to protect the NW. 
The shadow mask was aligned and fixed on top of the silicon chip by stereomicroscopy before 
the plasma treatment. Figure 3.1a and b schematically show that the shadow mask can 
completely cover the NWs. The plasma treatments were performed using plasma cleaner 
(Harrick PDC-32G) for 1 min. For comparison, several samples were treated with O2 plasma 
under the same conditions but without the shadow mask.  
After the plasma treatment, the shadow mask was quickly taken off from the chip and the 
PDMS replica was then aligned and stacked on the silicon chip to form an irreversible sealing 
(figure 3.2). Holes were punched through the PDMS replica on both ends of each microchannel 
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using a 20-gauge needle and the tubings were inserted into the hole to complete the microfluidic 
device (figure 3.3a). The successful injection of fluid into the microfluidic channel through the 
tubing is shown in figure 3.3b. 
 
 
Figure 3.1. Illustration of the plasma treatment for pre-functionalized chip in the presence of shadow mask. 
(a) Schematic illustration of the O2 plasma treatment of a shadow mask protected chip. (b) Enlarged side view. The 
bio-functionalized NW is protected by the shadow mask from the plasma.  
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Figure 3.2. Irreversible sealing formed between the PDMS and silicon chip. (a) images of a silicon chip 
and a PDMS replica that contains six channels. (b) The PDMS can be easily peeled off from the chip if use 
mechanical attachment. (c) An irreversible sealing can be formed between PDMS and silicon chip after oxygen 
treatment. 
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Figure 3.3. Demonstration of the microfluidic device integration. (a) The assembled microfluidic device 
with inlet and outlet (inset: the chip and the PMDS replica were permanently attached after plasma treatment). (b) 
The fluid can be successfully injected into the microfluidic channel. 
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3.2.4 Characterizations 
To study the protection effects of the shadow mask on the NWs during the plasma treatment the 
resistance and fluorescence of as-prepared and plasma treated NWs were measured using a 
semiconductor analyzer and fluorescence microscope (Axioskop, Carl Zeiss). The fluorescence 
intensities of NWs samples were further examined using microspectrophotometer (CRAIC 
Technologies) at emission wavelength of 365 nm. All of these measurements were performed at 
room temperature. 
3.2.5 Protein Detection 
To determine whether the activity of the biomolecules can be preserved by the shadow mask 
after plasma treatment, the target protein detection of the as-prepared and plasma treated NWs 
were performed. Two different biosensors, one is Aptamer-PPy NWs and another one is surface 
modified PANI NWs, were used for the detection of IgE and IgG respectively. The proteins 
detections were carried out by dividing the NWs into two groups for each case: 1) as-prepared 
functionalized NWs (G-1) and 2) shadow mask protected samples treated with O2 plasma (G-2). 
The conductance of the NWs was monitored by applying a constant current (100 μA) using a 
semiconductor analyzer. When the conductance of the NW was stabilized in the PBS solution, a 
droplet of non-specific protein bovine serum albumin (BSA) solution was added, and followed 
by several droplets of target protein solution with different concentrations. 
The integrated microfluidic biosensor based on aptamer-PPy NWs was also developed 
for the detection of IgE protein. The BSA solution was first flowed into the microchannel and 
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then followed by several IgE solutions with different concentration. The same conductance 
measurement conditions mentioned above were employed. 
3.3 RESULTS AND DISCUSSION 
3.3.1 Resistance 
The I-V curves of aptamer-PPy NWs with and without the protection of the shadow mask when 
treated by O2 plasma are shown in figure 3.4. The measured resistances of the as-prepared NWs 
are about 200 Ω and 320 Ω. After the O2 plasma treatment, the NW that exposed directly to the 
plasma was broken, showing no current in the I-V curve. On the other hand, the resistance of the 
shadow mask protected NW remains similar (~600Ω) to its resistance before the plasma 
treatment. It is well known that plasma has been widely used for surface cleaning: it utilizes 
energetic ionized gas molecules to bombard the surface. Therefore, without any protection, it is 
easy to create tiny breaks on NWs with O2 plasma. These breaks can be prevented via the use of 
a shadow mask and is confirmed by the results demonstrated above.  
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Figure 3.4. I-V curves of aptamer-PPy NWs before (solid lines) and after (dash lines) the plasma treatment 
with (red) and without (blue) the protection of shadow mask.  
3.3.2 Fluorescence 
Fluorescence images of the NWs functionalized with fluorescently labeled biomolecules were 
taken by fluorescence microscopy as shown in figure 3.5a. To some extent, the damages on the 
NWs caused by plasma treatment can be represented by their fluorescence intensity changes. It 
can be observed from the images that a clear bright line (aptamer-PPy NW) was broken into two 
short lines with reduced fluorescence intensity after the plasma treatment in the absence of the 
shadow mask. Conversely, the presence of shadow mask showed non-appreciable changes in 
fluorescence intensity after the plasma treatment. Quantitative characterization on the 
fluorescence of the NWs was further performed using a microspectrophotometer. The results are 
shown in figure 3.5b. The significant reduction in fluorescence intensity of the unprotected NW 
indicates that plasma treatment can easily damage the NW and the biomolecules. In contrast, 
only a small intensity reduction is observed for the shadow mask protected NW.  
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Figure 3.5. Fluorescence characterizations of the NWs. (a) Fluorescence images of aptamer-PPy NWs 
before and after the plasma treatment with and without the protection of shadow mask. (b) The fluorescence 
intensity of samples before (solid line) and after (dash line) plasma treatment with (red) and without (blue) the 
protection of shadow mask. 
(a) 
(b) 
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3.3.3 IgE Protein Detection 
In order to determine whether the bioactivity of the biomolecules on the NWs can be preserved 
by using a shadow mask during the plasma treatment, the proteins detections were carried out 
with two groups of NWs including as-prepared functionalized NWs (G-1) and shadow mask 
protected samples treated with O2 plasma (G-2). The IgE detection result (figure 3.6) shows that 
the sensitivity of the NWs in G-2 slightly decreased compared to the NWs in G-1. However, the 
measured values of G-2 remain within the distinguishable level for IgE detection. The result 
shows that the shadow mask plays an important protective role in preserving the bioactivity of 
the functionalized NWs from the O2 plasma treatment. 
 
 
Figure 3.6. Comparison of IgE detection responses of PPy NWs before plasma treatment (G-1) and after 
plasma treatment with the protection of shadow mask (G-2). 
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Figure 3.7. IgE detections using aptamer-PPy single NWs based microfluidic biosensors. (a) Normalized 
real-time response of microfluidic biosensor (red) and PPy NW (blue) to BSA and IgE solutions. Arrows indicate 
the points of injecting protein solution. (b) The sensitivity of the microfluidic biosensor as a function of IgE 
concentration. 
3.3.4 Microfluidic Biosensor for IgE Detection  
Finally, an integrated microfluidic biosensor device based on aptamer-PPy NWs was employed 
for IgE detection. As shown in figure 3.7a, a stepwise response was observed upon the injection 
of IgE solutions into the microchannel. As the IgE concentration increased from 0.01 to 100 nM, 
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the conductance of this microfluidic biosensor consistently increased from 0.58% to 1.56%. 
Remarkably, the response and stabilization times of this microfluidic biosensor was very fast 
(few seconds), which is desirable for biosensors. Moreover, the slight changes on the negative 
control of PPy NW corresponding to BSA and IgE solutions indicate an excellent specificity for 
this microfluidic biosensor.  
The sensitivity of this microfluidic biosensor was calculated from three biosensors and 
shown in figure 3.7b. This microfluidic biosensor was very sensitive showing a ~0.5% change in 
conductance at the lowest IgE concentration of 0.01 nM (2 ng/mL). A dynamic range from 0.01 
nM (2 ng/mL) to 100 nM (20 μg/mL) was obtained for this microfluidic biosensor. These results 
demonstrate the applicability of this microfluidic biosensor to detect IgE concentration below 
and above 1.2 nM (240 ng/mL) which has been established as the normal level of IgE in non-
allergic adults. 
3.4 CONCLUSIONS 
We have successfully demonstrated that employing a shadow mask protects pre-functionalized 
NWs during O2 plasma treatment and enables the integration of irreversible sealed microfluidic 
devices. Significant differences were observed between the bio-functionalized nanowire sensors 
that treated by O2 plasma with and without using a shadow mask. In the absence of a shadow 
mask NWs are destroyed after plasma treatment as shown by the resistance increase and 
fluorescence intensity decrease. On the other hand, the shadow mask protected NWs maintained 
a low resistance and high fluorescence intensity post plasma treatment. The detection of IgE 
protein by aptamer-PPy further demonstrated that the shadow mask can preserve the bioactivity 
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of the functionalized NWs and that a microfluidic biosensor can be fabricated after the plasma 
treatment. The integrated microfluidic biosensor developed in this work exhibited fast response 
and rapid stabilization times. Significantly, this simple but novel approach provides an easy way 
to assemble irreversiblely sealed nanomaterilals-based microfluidic device without deactivating 
the pre-functionalized detection elements. Therefore this technique can be widely applied on 
nanomaterials-based microfluidics for the purposes of biomolecules detection and clinical 
diagnostics.  
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4.0  CHEMICAL SYNTHESIS OF PANI PATTERNS 
4.1 INTRODUCTION 
The development of science and technology of nanomaterials has created great excitements and 
expectations in the past decades. Nanomaterials can be classified according to the dimensionality 
(D) of their feature into 0D, 1D, 2D, and 3D nanostructures. 0D nanostructures including 
quantum dots, nanoparticles, nanosphere, isolated molecules and atoms are point structures with 
nanoscale in all dimensions.
117
 1D nanostructures such as nanotubes and nanowires are structures 
with non-nanoscale only in one dimension.
118, 119
 2D nanostructures, for example nanosheet, 
nanoplates, nanobelts, and nanodisc, are structures with nanoscale in one dimension.
120
 Lastly, 
3D nanostructures like nanotetrapods, nanoflowers, and nanocombs are arbitrary structures, 
which contain nanoscale features in any of three dimensions.
121
  
The most important aspect of nanomaterials is their special properties associated with 
their small dimensions. A fundamental characteristic of nanomaterials is the high surface-area-
to-volume ratio, which lead to a number of unique physical and chemical properties such as high 
molecular adsorption, large surface tension force, enhanced chemical and biological activities, 
large catalytic effects, and extreme mechanical strength.
122
 The nanomaterials are thus highly 
useful for a wide range of nanotechnology fields especially in nanoelectronics and 
bioelectronics,
117, 118, 120-122
 resulting in a dramatically fast growth in the nanosensors field. 
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Among varies of nanosensors, 0D (nanoparticles) and 1D (nanotube and nanowire) 
nanomaterials showed great performance improvements in terms of sensitivity and detection 
limit compared with thin films due to their high surface-to-volume ratio. However, when scale-
down the thickness of thin films within nanoscale, the nanometers-thin films then become to 2D 
nanomaterials. This raises an interesting question: for the 1D and 2D nanostructutres which has 
better sensing performance if their surface-area-to-volume ratios are similar (or close). It is 
highly believed that the 2D nanostructure would possess comparable sensing performance to that 
of 1D nanowire. First of all, similar surface-area-to-volume ratio allows the 2D nanostructure to 
have similar binding sites density as the 1D nanowire. Therefore, ideally, similar target densities 
are expected to be bound on both nanostructures, leading to comparable effects on these two 
transducers. Secondly, the electrical properties of a 2D nanostructure and a 1D nanowire are 
expected to be close since both of these two structures are still at nano-scale. Thirdly, according 
to the biosensor sensing mechanism, the thickness of the nanomaterial strongly determines the 
sensor’s response. Because the thickness for both 1D and 2D nanoctructures is the same, similar 
volume ratio between the volume that can be affected by surface potential change and the total 
volume of the material is expected. As a result, similar response change is likely to be achieved. 
It is of interest that if the 2D nanomaterials can exhibit similar performances to that of 1D 
nanomaterials because 2D materials offer many benefits in the emerging field of large-area and 
low-cost electronics.  
Carbon is one of the most notable examples, which has all dimensionalities of 0D 
fullerene, 1D carbon nanotubes (CNTs), 2D graphene, and 3D graphite, diamond, and 
amorphous carbon.
123
 In 1D structure, carbon atoms are arranged as single wall or multiwall 
carbon nanotubes (SWCNTs/MWCNTs). Because of their very small diameters and relatively 
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long lengths (up to several millimeter), CNTs are prototype hollow cylindrical 1D quantum 
wires. Depending on the atomic orientations along the tube axis, the CNTs exhibit unique 
electrical and mechanical properties. With those properties, CNTs have been the center of 
attention for the development of advanced electronics, sensors and fuel cell platforms in the past 
years.
123
 Semiconducting CNTs can be used to build up FET devices that can work at room 
temperature and in ambient conditions. The majority of research towards biosensing involves the 
interactions of proteins with carbon nanotubes. For example, CNTs based sensor devices have 
shown the ability to detect gases such as NO2, NH3, H2, CO, NO, CO2, and O2.
123
 In addition, Li 
et al.
86
  studied the complementary detection of prostate-specific antigen by using a CNTs based 
FET device. They found the limit of detection was ca. 500 pg/mL, or 14 pM, at a signal-to-noise 
ratio of 2. Many studies about CNTs FET biosensors showed that the detection limit of such 
device can be as low as hundreds picomoles.
124
  
Carbon atoms also form a flat monolayer, tightly packed in a 2D honeycomb lattice, 
called as graphene.
123
 Graphene exhibits exceptional strength and possesses many other novel 
electrical and optical properties that have scientists buzzing. The electronic, thermal, and 
mechanical properties of graphene make it attractive for a variety of potential applications, 
including sensors, electronics, energy storage, and solar. While not as matured, the field of 
graphene-based sensors is dramatically growing, and their electrical response to various chemical 
species is qualitatively similar to CNTs. Examples have been reported for the detection of both 
NO2 and NH3 with graphene-based devices.
123
 The detection limits range between the parts per 
billion (ppb) and parts per million (ppm) levels. This sensitivity is comparable to CNT-based 
sensors. Furthermore, graphene-based FETs can be employed for biomolecule sensing. Chen and 
co-workers
125
 reported that large-scale chemical vapor deposition (CVD) grown single- and few-
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layer graphene films are highly sensitive to DNA hybridization. The sensor detection limit was 
found about 10 nM for single stranded DNA. Other studies demonstrated that graphene-based 
sensor devices were capable of detecting targets as low as few nanomoles,
126
 which is 
comparable to that of CNTs-based sensors.  
Silicon nanomaterilas have drawn tremendous attention as a promising transducer in 
biosensors as well. Due to their excellent semiconducting properties, most of the 1D SiNWs 
sensors are designed as field effect transistor sensors. An early measurement made by Cui et al. 
reported the real-time detection of streptavidin binding to biotin-modified SiNW FET.
30
 They 
found out that biotin-modified SiNW FET was able to detect streptavidin at the concentration of 
10 pM. Specific PNA-modified SiNW-FET sensors have recently been established to diagnose 
Dengus virus infection.
32, 127
 The detection limit of this SiNW-FET biosensor was claimed to be 
10 fM. With improved measurements approaches, Liber’s group have found that the detection 
limit for SiNW-FET sensors can be as low as ∼0.75 pM in the linear regime to ∼1.5 fM in the 
sub-threshold regime.
128
 
The silicon 2D thin films have been studied for biosensors use too. Conde and 
coworkers
129
 reported the use of amorphous Si thin film ISFETs for the label-free detection of 
covalent DNA immobilization and hybridization. These thin-film transistors can be turned on 
through a voltage applied to an electrolyte in contact with its dielectric layer, and remain 
functional after the functionalization of its surface with DNA. The amorphous Si ISFETs were 
shown to be sensitive to different levels of hybridization.  A sensitivity of approximately 50 nM 
has achieved for the sensor device. The comparison between 1D and 2D silicon materials reveals 
that the detection limits for 1D SiNWs are typically lower than that of 2D Si thin films, but the 
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2D Si thin film still showed good sensing performances exhibiting detection limit in nanomoles 
scale. 
In addition, metal oxides have been intensively studied for sensor applications. A typical 
example is Zinc oxide (ZnO). Many 1D ZnO based biosensors have been reported. Wang et. 
al.
130
 have demonstrated a probe-free and highly sensitive 1D ZnO FET biosensor for detecting 
biologically and chemically charged molecules. The principle of the srnsor relies on the 
nonsymmetrical Schottky contact under reverse bias. Owing to the nonsymmetrical Schottky 
contact configuration, this ZnO sensor had much higher sensitivity than that of the ohmic contact 
configuration because a few molecules at the junction region can tune the “gate” that effectively 
changes the conductance. A low detection limit of 2 fg/mL has been demonstrated for 
hemoglobin with a wide dynamic range from 2 fg/mL to 20 ng/mL.  
ZnO 2D nanostructures like thin film, network also have been utilized for biosensor uses. 
A zinc oxide nanostructured thin film with rough surface has been reported for the detection of 
cholesterol.
131
 Amperometric and photometric studies reveal that the 2D ZnO sensor was highly 
sensitive to cholesterol over a wide concentration range from 0.12-12.93 mM (5-500 mg/mL). 
This high sensitivity was attributed to the large surface area of ZnO thin film for effective 
loading of the cholesterol receptors. Malhotra and colleagues demonstrated a hexagonal ZnO 
nanocrystalline film for the detection of M. tuberculosis.132 The 2D ZnO thin film exhibited an 
extremely low detection limit of 1 pM, and a wide detection range from 1 pM to 1uM. This low 
detection limit was achieved due to the high surface roughness (~3.51 nm) of the 2D ZnO film, 
which ensured a large surface-to-volume ratio for the sensor. 
A summary of typical 1D and 2D materials based biosensors is listed in table 1. These 
sensors rely on either electrochemical or electrical detection principle. Interestingly, both of the 
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1D and 2D nanomaterials have excellent sensor performances, showing very low detection limit 
and wide detection range. Despite that the 1D nanomaterials slightly have better performance 
than that of 2D nanomaterials in general, 2D nanomaterial biosensors still possess low detection 
limit at or even less than nanomoles scale, which is comparable to that of 1D nanomaterials. As 
discussed previously, one key characteristic of nanomaterials is their small dimension. Such 
small size thus offers very high surface-to-volume ratio, leading to a number of unique physical 
and chemical properties. Therefore, even with different dimensionality, 2D nanomaterials still 
have similar or close surface-to-volume ratio with 1D nanomaterials. As a result, the 2D 
nanomaterials are capable of exhibiting comparable performance to 1D nanomaterials as sensors. 
Table 4.1. A summary of 1D and 2D nanomaterials for sensor uses.
32, 127, 129, 130, 132-137
 
 
Conducting polymers are an important type of versatile materials for sensing application 
because they not only possess unique properties but also can be used as immobilization matrices, 
receptors and in biosensors. In recent years, studies focused on conducting polymer biosensors 
have shown a trend towards the development of nanostructured conducting polymer biosensors, 
owing the ability to change the sizes and structures, and hence the properties, of these 
nanomaterials.  
Material Analyte Detection Details
SWCNT CgA 100 pM-1 nM
SWCNT CEA 10 ng/ml
SiNW PSA, CEA 75 fg/ml, 100 fg/ml
SiNW Mucin-1 75 fg/ml
ZnO Hemoglobin 2 fg/ml, 2 fg/ml-20 ng/ml
Graphene Glucose 20 pM
Graphene Cholesterol 0.5 nM 
Si thin film DNA 50 nM  
ZnO thin film DNA 1 pM  
Gold nanoshell CACNA1F 10 ng/ul
1D
2D
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1D conducting polymers, such as nanowires and nanotubes, have attracted a great deal of 
interest for the design of biosensors. A conducting PANI nanotube array based ultra-sensitive 
biosensor has been developed for DNA hybridization detection. It demonstrated an extremely 
high sensitivity of 1.0 fM and good hybridization specificity even at the ultralow concentration 
of 37.59 fM.
138
 Besides, a nanogapped microelectrode-based biosensor array for ultra-sensitive 
electrical detection of microribonucleic acids (miRNAs) has been realized by the target-guided 
deposition of PANI nanowires as the in situ signal amplification.
139
 The target miRNA can be 
quantified in a range from 10 fM-20 pM with a detection limit of 5.0 fM. 
The 2D conducting polymers biosensors have been reported in literatures as well. For 
example, an organic thin film transistor glucose sensor with a channel consisting of glucose 
oxidase immobilized by a spin-coating technique on poly (3,4-ethylenedioxythiophene-poly 
(styrene-sulfonate) (PEDOT-PSS) conducting polymer film has been reported to have a rapid 
response time (within 20 s). But the detection limit for the sensor was about 1.1 mM under 
optimized testing conditions. Moreover, a nanostructured conducting polymer layers based 
glutamate biosensor for the in vivo measurement of glutamate release stimulated by cocaine was 
reported.
140
 The glutamate micro-biosensor demonstrated a detection limit of 100 nM, a response 
time less than 10 s, and a wide linear range between 0.2 and 100 uM.  
Notably, a unique property for conducting polymers is that they can be easily fabricated 
via chemical approaches. Therefore the surface roughness of the conducting polymers can be 
controlled by the synthesis methods. Then it is of interest to compare the sensing performance 
for the 1D and 2D nanomaterials with similar surface roughness, surface-area-to-volume ratio, 
and physic properties. As shown in previous, for same materials, the sensors constructed from 
their 1D and 2D nanomaterials have similar behavior. Therefore comparable sensing 
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performance is expected for both 1D and 2D conducting polymer nanomaterials. This motivated 
us to fabricate PANI with the 1D and 2D nanostructures. Because the surface roughness of PANI 
can be well-controlled, it is highly believed that the 2D PANI nanomaerials would exhibit 
similar performance to that of the 1D nanomaterial as sensors. In this chapter, the fabrication and 
characterization of 1D and 2D PANI nanomaterials are studied and their physic properties are 
compared.  
4.2 EXPERIMENTAL  
4.2.1 Fabrication of PANI Patterns 
The whole PANI patterns fabrication procedure is schematically illustrated in figure 4.1. Au 
electrodes were patterned and outlined on a wafer by a standard photolithography and lift-off 
process. The polymethylmethacrylate (PMMA) nanochannels with widths ranging from 200 nm 
to 50 nm can be created between Au electrode pairs by e-beam lithography. Detailed device 
fabrication procedures have been presented by our group previously.
52, 53
 In this chapter, 100 nm 
PMMA channels were used as an illustrative case. Before the chemical synthesis, the wafer 
patterned with PMMA nanochannels was treated with oxygen plasma for 30s to remove the 
residue inside the nanochannels and to improve the wettability of the surface. This process 
enhances the adhesion between the PANI film and SiO2 layer which is a very important factor in 
later lift-off process. A dilute polymerization method
141, 142
 was employed to coat a uniform 
PANI thin film on the whole wafer. In a typical procedure, a prefabricated wafer was immersed 
in 180 mL of 0.5 mol/L aqueous HClO4 solution. Aniline monomer (0.91 mL) was then added 
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into the HClO4 solution and stirred for 30 min at ~0-5 °C (ice bath) to form a uniform mixture. In 
a different beaker, the oxidant, (NH4)2S2O8 (APS), was dissolved in 20 mL of aqueous HClO4 
solution (the molar ratio of aniline/APS is 3) and cooled to ~0-5 °C. The polymerization was 
initiated by combining the two solutions. The mixture was stirred for 4 hrs at ~0-5 °C to 
accomplish the formation of PANI thin film (figure 4.2). After the polymerization, the wafer was 
taken out from the solution and washed with deionized water to remove adhering PANI 
precipitate. The green color shown on the wafer upside indicates that a thin layer of PANI film 
was successfully coated on its surface. Then the PANI coated wafer was dried in vacuum. 
Finally, the PANI film coated wafer was immersed in acetone for 5 min to dissolve the PMMA 
layer, and the PANI patterns were obtained by cleaning the wafer with ultrasonication for a few 
seconds and rinsing it with deionized water 3 times. After the lift-off process, the PANI patterns 
samples were stored for future use under vacuum conditions.  
 
Figure 4.1. Schematic illustration of the fabrication process for 1D PANI-NWs. (a) pre-patterned PMMA 
nanochannels on a 4-inch wafer. (b) Chemical synthesis of PANI thin film. Polymerization condition: [aniline]=5 
mM, [aniline]/[APS]=3, [HClO4]=0.5 M, temperature=~0-5 °C (ice bath), stirring of the reaction mixture and 
reaction time=4 h. (c) PANI thin film coated wafer after the chemical polymerization. (d) PANI-NW arrays after the 
lift-off process. 
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Figure 4.2. The PANI polymerization steps and mechanism. 
4.2.2 PANI Patterns Fabrication Optimization 
The fabrication method of the PANI NW is the same method introduced in the previous section 
except the improvement of the lift-off process with a bi-layer photoresist. In the lift-off process 
for PANI coated e-beam lithographically patterned PMMA nano-channels, retention could occur 
resulting in the unwanted PANI remaining on wafer. This usually happens when the PMMA is 
completely covered by PANI film, leaving no gap in the PANI coating for the solvent to 
penetrate and dissolve the PMMA. To address this and improve the uniformity of the PANI 
nanowire dimensions, a bi-layer photoresist lift-off process was introduced in the patterning of 
PMMA nano-channels as shown in figure 4.3. LOR is not photosensitive but is freely soluble in 
conventional aqueous developers, which makes it an ideal bottom layer. Typically, LOR was 
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applied on the wafer by spin coating at 4000 rpm for 45 seconds, and baked on hot plate at 195 
°C for 9 minutes. The PMMA was spin coated on top of the LOR and baked in the oven for 30 
minutes. After e-beam patterning, the patterns were developed in MIBK/IPA developer for 60 
seconds, the wafer was rinsed with DI water and blown dry with N2. Afterward, the LOR layer 
was etched in diluted AZ-400K developer (AZ-400K:H2O=1:4) for 60 seconds to create an 
undercut and the wafer was rinsed with DI water and blown dry with N2 gas. The undercut 
structure enabled a cleaner lift-off of the PANI film leaving uniform PANI nanowire on the 
wafer. 
 
Figure 4.3. Schematic illustration of bi-layer lift-off process. 
4.2.3 Characterizations 
Optical microscopy and scanning electron microscopy (SEM) were used to examine the PANI-
NWs and the electrical properties were measured using a semiconductor device analyzer. The 
chips containing PANI-NWs were place on a probe station, on which the Au electrodes were 
connected to semiconductor device analyzer by sharp probes. The resistances of these PANI-
NWs were measured at first when they were taken out from vacuum. Then these PANI-NWs 
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were immersed in to HCl (0.1 M) solution for a short time, and after that, their resistances were 
measured again. 
4.2.4 Biofunctionalization 
To prove that the antibody can be successfully immobilized onto the PANI-NWs, a fluorescence 
labeled antibody was used to functionalize the PANI-NWs. The antibodies were covalently 
bonded to the PANI-NWs in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDC) and N-hydroxysuccinimide (NHS).  
Entrapment during polymer synthesis and covalent attachment post polymerization are 
the two most widely used methods of biofunctionalizing a conducting polymer. The major 
disadvantages of the entrapment method are a loss of biological activity due to the adverse 
synthesis conditions and inaccessibility of the biomolecule as it is buried inside the polymer 
matrix. Covalent functionalization, on the other hand, immobilizes the biomolecule on the 
polymer surface making it fully accessible for interaction with its complementary target giving 
higher sensitivity and a faster responding biosensor. For covalent immobilization of 
biomolecules to conducting polymers, EDC and NHS have been widely employed. Figure 4.4 
and 4.5 shows the functionalization and reaction mechanism for covalent biomolecule binding on 
PANI by EDC/NHS. Briefly, EDC/NHS is first attached to the secondary amine groups on the 
PANI nanowire or carboxylic groups on the biomolecules and the other end of the linker 
molecule is attached to the amine groups of the biomolecules or the secondary amine groups on 
the PANI nanowire surface. 
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Figure 4.4. The immobilization of aptamers or antibodies onto the surface of PANI nanowires.  
 
 
Figure 4.5. The mechanism of using EDC/NHS as linker reagents for the immobilization of antibodies onto 
the surface of PANI nanowires.  
A PBS solution containing 0.1 M EDC, 0.1 M NHS, and 100 μg/mL of the antibody was 
added onto the PANI-NWs for 3 hours at room temperature for the immobilization. The PANI-
NW was then thoroughly rinsed with PBS to remove physically adsorbed antibodies after the 
immobilization. To prevent possible nonspecific adsorption of other biomolecules to the PANI-
NWs, PBS solution containing 200 μg/mL bovine serum albumin (BSA) was then dropped onto 
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PANI-NWs for 30 minutes to block the free sites on their surface. After the immobilization of 
antibody, the PANI-NWs were checked by fluorescence microscopy. The functionalization of 
CK-MB antibody was also executed using the same procedure.  
4.2.5 Field-effect Transistor Measurements 
Similar to conventional three-probe FET structure, the single nanowire FET structure was 
established by using two Au electrodes as source and drain electrodes, and instead of using 
conventional gate, an additional Au electrode was employed as the gate electrode (figure 4.6). 
For the FET measurements, the gate voltage (Vg) provided by the power supply was applied to 
the conducting gate, which is separated from the source and drain electrodes, to modulate the 
current flow through the nanowire. The source-drain voltage (Vsd) generated the source-drain 
current, which is enhanced or quenched upon application of a given gate voltage.  
For the biomolecules detection, the entire area of the sensing device was covered with a 
phosphate buffer saline (PBS) solution containing biomarkers. A chip containing several 
nanowires was placed on a probe station and connected to a semiconductor device analyzer 
(Agilent Technologies B1500A) through three probes. A probe was attached to the source, drain, 
and gate electrodes. The source-drain voltage and gate voltage were provided and controlled by 
the semiconductor device analyzer, which also collected the source-drain current during the 
measurements. Typically, the gate voltage was swept from 0.5 V to -0.5 V with a 5 mV 
sweeping step and the source-drain voltage was scanned from 0 V to 0.5 V with a step of 0.1 V. 
A baseline of the FET sensor was first acquired by adding a PBS solution onto the sensor, and 
then the detection signal was obtained by adding PBS solutions containing the target biomarker. 
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Figure 4.6. Schematic illustration of the PANI-NWs FET measurement with an electrolyte-gate 
configuration, in which Pt wire is employed as the gate electrode. 
4.3 1D PANI NANOWIRES 
4.3.1 Morphology 
An optical microscope was employed to examine the samples. Figure 4.7a shows the optical 
micrograph of a PANI thin film coated slide cut from a whole wafer. The slide contains four 
small chips, and each chip has 16 pre-patterned PMMA nanochannels and 8 Au electrode pair 
arrays. After the lift-off process the PANI thin film is removed leaving 1D PANI-NWs on the 
patterned area. Compared to figure 4.7a, the color of the slide changes (figure 4.7b), indicating 
the completion of the lift-off process. Magnified optical micrographs of the PANI-NWs from 
different places on one chip are shown in figure 4.7c. Eight PANI-NW arrays (16 PANI-NWs) 
are fabricated on the chip, and three of them are shown in the figure.  
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Figure 4.7. (a) Image of a PANI thin film coated slide. (b) Image of a slide after the lift-off process. The 
different colors showing in (a) and (b) indicates the successful completion of the lift-off process. (c) Optical 
microscopy images of the PANI-NWs from one chip. (d) SEM images of the PNAI-NWs from different positions of 
one chip.  
Close examination of the PANI-NWs by scanning electron microscopy (SEM) reveals 
that these PANI-NWs are straight and well-defined. As shown in the SEM images (figure 4.8), 
the width and the length of the PANI-NWs are about 100 nm and 12 um respectively, which are 
the same as the dimensions of the PMMA channel. It is important to note that, the heights of the 
PANI-NWs are determined by the PANI synthesis time and the dimension of the PANI-NWs can 
be controlled by the pattern sizes and chemical reaction time. Remarkably, the chemical 
synthesis and lift-off treatment are parallel procedures, thus many wafers can be processed at the 
same time, which allows high throughput for the production of PANI-NWs.  
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Figure 4.8. SEM images of the PANI-NWs. (a) and (b) SEM images of two different PANI-NWs from 
same chip. Good uniformity in the dimension of these PANI-NWs can be clearly observed. (c) and (d) The 
hierarchical structure of the PANI NW are clearly shown in the high magnification SEM images. 
The structure of the PANI NWs can be observed in the high magnification SEM images 
shown in figure 4.8. The SEM images show that the PANI-NWs have two structures including a 
primary structure (nanowire) and a secondary structure (nanofiber). A top view of the PANI-
NWs shows that there are many nanofibers along the NW. The average length of these 
nanofibers is estimated about 30 nm with diameters of 5 to 15 nm. The diameter of the tip of the 
individual nanofiber is a few nanometers. Interestingly, the close inspection of the PANI-NWs 
shows that the nanofibers are grown toward the central axis of the nanowire. This unique 
hierarchical structure provides much larger specific areas than conventional nanowire structures, 
thus it is expected to exhibit superior performance in many applications.  
Atomic force microscopy (AFM) images (figure 4.9) of a single PANI-NW further 
confirm its concaved shape. Because of the AFM tip convolution, the NW in the AFM images 
looks wider than that in SEM images. However, these AFM images still qualitatively reveal the 
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concaved-shape of the NW. Because of this unusual shape, the NW exhibits a high surface area 
to volume ratio, which is especially desired in NW-FET biosensors. In general, the detection 
principle of nanowire-based FET biosensors relies on the field gating effect of charged 
molecules on the carrier conduction inside the NW. Therefore it is naturally expected that the 
higher sensitivity could be achieved when a higher surface area to volume ratio between the part 
of the NW gated by surface charges and the whole body of the NW is obtained. A recent report 
demonstrated that the sensitivity of NW-FET sensors can be exponentially enhanced in the sub-
threshold regime where carriers in NWs have long screening lengths and the field effect of 
surface charges can gate the whole NW, fully utilizing the high surface volume ratio of NW.
128
 
In light of this advancement, another potential approach to utilize a higher portion of the NW 
would be to alter the shape of NW to create more effective surface area. Therefore the higher 
surface volume ratio of the PANI-NWs owing to their concaved-shape is conducive to increase 
the portion of the NW that can be gated by the surface charges.  
 
Figure 4.9. AFM images of a single PANI-NW, which details the concave shape of the NW. 
For PANI-NWs, its primary structure is defined by the PMMA patterns which are 
obtained by nanofabrication techniques. On the other hand, its secondary structure is achieved by 
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a chemical reaction. The combination of nanofabrication and chemistry allows the formation of 
this unique hierarchical structure. The growth mechanism for the PANI nanofibers has been 
proposed by other groups,
141, 142
 which is similar to a model introduced by Liu et al.
143, 144
 to 
address the stepwise electrochemical polymerization of PANI-NW arrays. The solid substrates 
and bulk solution are two potential nucleation sites for the growth of PANI in chemical oxidative 
polymerization. These two sites compete with each other thus showing different nucleation rates 
for PANI. As reported, the polymerization time for PANI is strongly dependent on the 
concentration of reagents (e.g. aniline monomer, oxidant, and dopant).
145, 146
 When concentrated 
aniline (or oxidant) is used, the nucleation of PANI in bulk solution is at a similar or faster rate 
than that on solid substrates. In contrast, for dilute concentrations of aniline (or oxidant), 
heterogeneous nucleation happens first on solid substrates since less energy is required. As a 
result, most active nucleation sites are generated on the solid substrates at a relatively faster rate 
when the polymerization is initiated. These active sites would further minimize the interfacial 
energy barrier for the following growth of PANI on the substrates. Meanwhile, after induction, 
PANI also simultaneously forms in the bulk solution. The polymerization in the bulk solution 
consumes some reactive aniline cation-radicals and oligomeric intermediates and in turn 
suppresses the growth rate of PANI on the solid substrates. The slow polymerization on the 
substrates only allows PANI to grow from the active nucleation sites generated in the initial 
stage of polymerization.  
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Figure 4.10. PANI thin film thickness versus polymerization time. The film thickness depends linearly on 
the polymerization time. The thickness of the PANI film was measured by atomic force microscopy (AFM) with 
non-contact mode. The standard error in each polymerization time was calculated from three samples. 
Significantly, an advantage of this chemical synthesis method is the capacity to control 
the thickness of the PANI film in a simple way. The relationship of the PANI film thickness 
measured by AFM and the polymerization time is represented in figure 4.10. The linear 
regression line (dashed line) indicates that the growth rate of the PANI film was kept 
approximately constant (~24 nm hr
-1
). Thereby, it is convenient to estimate the thickness of 
PANI film according to the synthesis time or to obtain PANI thin film with expected thickness 
by controlling the polarization time. 
4.3.2 Patterning Improvement 
The NW uniformity on a 4 inch wafer is critical to the quality of the patterned PANI-NWs. Thus 
the NW shape was examined using microscopy. The PANI-NWs and their position on a wafer 
are shown in figure 4.11. A total of five positions and of ten PANI-NWs were examined. All 
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straight and narrow PANI-NWs are well-patterned in between the Au electrode pairs, showing 
excellent shape uniformity.  
 
Figure 4.11. Microscopy images of PANI-NW arrays at different positions on a 4 inch wafer. These NWs 
possessed very good shape uniformity.  
Beside the good uniformity achieved by the bi-layer photoresist lift-off process, a good 
insulation for the FET device was also obtained. Previously, the lack of a bottom layer 
photoresist caused the gold contacts to be directly exposed to the electrolyte solution when 
performing the measurements resulting in a very strong leakage current between the gate and 
source electrodes. Using the bi-layer photoresist lift-off process, only the top layer resist was 
removed after the lift-off, leaving the bottom photoresist on the surface of the whole wafer. 
Hence the bottom photoresist played an important role for the electrical isolation among the gold 
contacts and the solution (figure 4.12). This new device configuration limited the leakage current 
to a great extent, giving better I-V profiles for the PANI-NWs and allowing greater device 
performance.  
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Figure 4.12. (a) Possible current leakages through the electrolyte. (b) The current leakages are limited by 
excellent insulations. 
4.3.3 Uniformity 
The uniformity of the PANI-NWs was investigated using a SEM and a semiconductor device 
analyzer. Rather than the conventional definition for uniformity, which is concerned more about 
the size of the object, the uniformity of the PANI-NWs includes two aspects: their dimensions 
and their electrical properties. As shown in figure 4.13, two PANI-NWs from different places on 
one chip have almost the same size and morphology, showing an excellent uniformity. It is also 
important to note that even for a single PANI-NW, its width is uniform from one end to the 
other. Although the fabrication of NWs on large areas can be achieved by many methods, such as 
self-assembly, nanoimprint lithography, lithographically patterned nanowire electrodeposition, 
etc, uniformly sized structures are rarely obtained. For example, the polymer nanowires formed 
by self-assembly exhibit low uniformity for single wires because a less controllable solvent 
annealing is involved in the patterning process,
51
 and the metal nanowires fabricated by 
lithographically patterned nanowire electrodeposition (LPNE)
45
 are not straight due to the 
influence of the contamination on the photolithography. In contrast to these methods, well-
controlled e-beam lithography patterning and lift-off techniques, and well-established chemical 
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polymerization are employed in this report, thus enabling the achievement of highly uniform 
PANI-NWs.  
 
Figure 4.13. (a) I-V curves of PANI-NWs kept in vacuum (square) and treated with HCl (circle). (b) 
Measured resistances of 16 PANI-NWs kept in vacuum (square) and treated with HCl (circle).  
Beside their uniform size, the PANI-NWs also exhibited uniform electrical properties. 
The resistances of 16 PANI-NWs from one chip were measured and are shown in figure 4.13. 
The first resistance measurements were performed right after the PANI-NWs were removed from 
a vacuum condition. Then the second resistance measurements for the same samples were carried 
out after they were treated with 0.1 M HCl solution for five minutes. All of these PANI-NWs 
were electrically continuous over their entire length no matter if they were kept in a vacuum or 
treated with HCl solution. After being removed from the vacuum, 13 out of 16 PANI-NWs 
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showed similar resistances with an average of 2.2 MΩ. After being treated with HCl solution, the 
resistances of all the 16 PANI-NWs fell into a small range with an average of 320 KΩ. The 
decrease in the resistance of these PANI-NWs after the acid treatment is caused by the 
protonation of the PANI.
147
 These results indicate that the PANI-NWs have excellent uniformity 
including not only their sizes but also their electrical properties, which is strongly desired for 
nanoelectronic device applications.  
4.3.4 Fluorescence 
The fluorescence microscopy images (figure 4.14) show that the fluorecence labeled antibodies 
are immobilized onto the surface of PANI-NWs. The nanowires exhibited a red flourescene 
(bright region) with uniformly distributed over their surface. Remarkably, clear fluorescence can 
be observed from most of the modified PANI-NWs, suggesting the excellent reproducibility of 
this covelent surface modification approach. 
 
Figure 4.14. Microscopy images (a) and (b) and fluorescence images (c) and (d) of PANI-NWs fabricated 
by chemical synthesis.   
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4.3.5 Detection of CK-MB Biomarker 
As discussed before, the PANI-NWs have very large specific areas and exhibit excellent 
uniformity which are advantageous for biosensor applications. The PANI-NWs FET biosensors 
were demonstrated. Since PANI-NWs are patterned on prefabricated Au electrode pairs, no 
device post fabrication steps are required. Because detections of most biomolecules are 
performed in an electrolyte environment, an electrolyte-gate is then employed. Similar to a 
conventional three-probe FET structure, two Au electrodes serve as source and drain electrodes, 
and instead of using conventional gate, a platinum (Pt) wire is employed as the gate electrode. 
The electrical measurements are performed in phosphate buffer saline (PBS) at ambient 
conditions.  
The drain current (Id) versus drain voltage (Vd) characteristics of a PANI-NW FET 
obtained as a function of different gate voltages (Vg) are shown in figure 4.15a. The value of Id 
rises upon increasing negative Vg to a positive Vd. This phenomenon is consistent with prior 
measurements performed on polyaniline nanowires.
148, 149
 Under similar conditions, but applying 
a positive Vg, a very weak gate modulation for this PANI-NW FET is observed which indicates 
that the n-channel transport mechanism does not function in the PANI-NW FET in PBS 
solutions. These results indicate that the PANI-NW is an excellent p-type material.  
To realize a PANI-NW-based biosensor, a creatine kinase (CK)-MB antibody is selected 
as the bio-recognition element for the proof-of-concept demonstration of detecting CK-MB 
biomarker by a PNAI-HNWs FET biosensor. CK-MB is a standard cardiac biomarker for the 
diagnosis of acute myocardial infarction (AMI).
150
 Detailed immobilization procedures can be 
found in our previous reports.
151
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Figure 4.15b shows the PANI-NWs FET sensor responses to the introduction of CK-MB 
and BSA collected at Vd=0.4 V and Vg=-0.4 V in ambient conditions. As expected, addition of 
the BSA to the sensor only caused a minor response even though a relevant high concentration of 
BSA solution (50 ng/mL) was used. This result shows that this biosensor does not respond to a 
non-specific target, thus exhibiting a very good specificity. In contrast, the introduction of the 
specific target CK-MB led to a significant increase in drain current (about 10% change referring 
to the base line) within a very short response time (40 s) despite the concentrations of CK-MB 
being very low (1 ng/mL). This drain current increase is possibly attributed to a chemical gating 
effect on the PANI-NW resulting from the specific binding event.
152
 The PBS solution of pH 7.4 
caused the CK-MB molecules to be negatively charged because it is higher than the isoelectric 
point of the CK-MB (pI=5.2–5.8). Therefore, the specific binding of the CK-MB and its 
antibody could induce a chemical gating effect, which in turn leads to the increase in drain 
current. As the concentration of CK-MB increased to 5 ng/mL and 50 ng/mL, the drain current of 
the sensor correspondingly increased by 17% and 29%, respectively. Remarkably, the clinical 
cutoff level for CK-MB is about 3.5-10 ng/mL,
153
 which falls into the detection range of this 
PANI-NWs FET sensor, thus demonstrating that this sensor is a promising candidate for clinical 
use. 
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Figure 4.15. (a) Id-Vg at different Vd for PANI-NWs FET. (b) Real-time detection results of CK-MB using 
PANI-NWs FET biosensor. 
4.4 2D PANI NANOBELTS 
4.4.1 Morphology 
The patterning process for 2D PANI nanobelts was similar to what was used for the fabrication 
of PANI-NWs except the photolithography steps. The electrode layout was simplified, which has 
a common source and common gate for the sensor device. The gaps between the source and 
drain electrode were designed to be 10, 50, and 100 microns. Although the length and width of 
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the 2D PANI are at the micro-scale, the PANI thickness was still kept ~100 nm by controlling 
the PANI thin film deposition time. 
Five kinds of patterns with different dimensions (length/width=10, 5, 1, 0.2, 0.1) were 
patterned on the electrodes for the purpose of studying the optimal pattern for sensor devices 
fabrication and tests. The microscopy images of patterned 2D PANI nanobelts are shown in 
figure 4.16. The PANI nanobelts were patterned between the source and drain electrodes with 
very sharp edges and well-controlled dimensions. This pattern technique ensured excellent 
contacts between the wire and the electrodes. The low magnification microscopy images of the 
PANI nanobelts in figure 4.17 clearly show the good shape uniformity of the patterns for each 
dimension.  
 
Figure 4.16. Five different dimensions (L:W=10, 5, 1, 0.2, 0.1) of the PANI patterns were designed to 
optimize the fabrication process and the following sensing tests. 
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Figure 4.17. Low magnification microscopy images of the patterned PANI nanobelts, which showed a 
good uniformity of the patterns. 
The details of the nanobelts surface can be observed from the SEM in figure 4.18. As 
shown, the nanobelts had very bright edges which suggest that the edges were thicker. Close 
examination of the PANI nanobelt revealed that there were many white dots on its surface. The 
SEM image of the surface at high magnification showed that the PANI nanobelt surface was as 
rough as the surface of PANI-NWs. The rough surface was achieved by the PANI thin film 
deposition method as explained previously. Significantly, the rough surface is advantageous to 
the sensor devices because it allows ultrahigh surface area to volume ratio and abundant surface 
area for the binding of biomolecules.  
 78 
 
Figure 4.18. SEM images of a photolithographically patterned PANI nanobelt.  
The topography of the 2D PANI nanobelt surface was studied by AFM at non-contact 
mode. It can be clearly observed that the film thickness was about 100 nm. The thickness is 
consistent for PANI-NWs fabricated under the same conditions. The AFM image (figure 4.19) 
also showed that the edges of the PANI nanobelt were higher than its other parts. The edges were 
about 600 nm height. The rough surface of the PANI was also observed from the AFM image. 
The diameter of grains on the PANI nanobelt surface was about 10 nm. These results confirm 
that the 2D PANI nanobelts have a rough surface and a high surface to volume ratio. These 
features were also observed from the 1D PANI NWs. Hence it is natural to expect that the 2D 
PANI nanobelts based sensors would have comparable performance to PANI-NWs sensors. 
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Figure 4.19. The AFM images of a 2D PANI nanobelt patterned by photolithography process. 
 
Figure 4.20. The rough surfaces of the (a) 1D  PANI-NW and (b) 2D PANI nanobelt provide abundant 
sites for the functionalization of antibody, giving similar antibody density on both wires. Therefore, the 2D PANI 
nanobelts are expected to have comparable sensing performance than the nanowires. 
In fact, the rough surface of the PANI film is one significant feature that could give the 
2D PANI nanobelts similar performance as the PANI-NWs. For both PANI nanostructures, only 
the upper surface of PANI is exposed to the solution and can be modified with antibodies. The 
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rough surface provides a large amount of binding sites for antibodies. Since the same 
functionalization method was used, the 2D PANI nanobelts should have similar antibody 
densities to the PANI-NWs (figure 4.20). Therefore, for the same target concentration, the 2D 
PANI nanobelts are able to capture more targets because more antibodies are available. As a 
result, this compensates for the effect of the dimension of the PANI nanobelts in some extent and 
gives the 2D PANI nanobelts comparable performance with the PANI-NWs. 
4.4.2 Resistance 
The resistances of the 2D PANI nanobelts were measured with a probe station and 
semiconductor analyzer. The resistances of PANI nanobelts with 10×10 um dimension are 
shown in figure 4.21. Five different nanobelts from different parts of a wafer were measured. 
The resistances of these wires were about ~6 k. The resistances of PANI nanobelts with other 
dimensions were listed in table 4.1. As shown, the resistances of PANI nanobelts with the same 
dimensions at different spots on the wafer were identical, indicating the good uniformity of these 
wires. 
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Figure 4.21. The resistance of five 10×10 um PANI nanobelts on a 4 inch wafer.  
Table 4.2. The resistances of PANI nanobelts with different dimensions at different positions on a wafer.  
 
4.4.3 FET Measurements 
The FET measurements of these 2D PANI nanobelts were performed using an electrolyte-gate 
configuration descried previously. The drain current (Id) versus gate voltage (Vg) characteristics 
of a PANI nanobelt FET obtained as a function of different drain voltages (Vd) are shown in 
figure 4.22a. The value of Id increased upon increasing negative Vg at positive drain potentials. 
Notably, higher drain currents can be obtained as the drain potential becomes more positive. As 
shown, the nanobelt was off when the gate bias was more positive than -0.6 V. As the gate bias 
went more negative than -0.6 V, the drain currents from the nanobelt were exponentially 
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increased. This phenomenon is consistent with the prior measurements performed on PANI 
NWs. The threshold voltage was about -0.6 V for the PANI nanobelt. In addition, no current 
leakages were found from these results, indicating that the additional PR layer played an 
important role in eliminating the leakage. These results confirmed that the 2D PANI nanobelts 
are an excellent p-type material. 
 
Figure 4.22. Id-Vd curves of a (a) 2D PANI nanobelt and (b) 1D PANI nanowire in 0.1x PBS solution. The 
2D PANI nanobelt showed comparable FET behavior with the nanowire.  
The I-V curve of a PANI-NW in 0.1x PBS solution is also given in figure 4.22b for 
comparison. Clearly, at the same measuring condition, the PANI-NW had less drain current. For 
a FET device, its drain current in the linear region is proportional to W/L, where W and L are the 
width and length of the gate electrode, respectively. Therefore, the drain current of PANI-NW 
was less than that of the 2D PANI nanobelts in the linear region because the PANI-NW has 
smaller W/L ratio. Compared to the drain current of the PANI-NW, the 2D PANI nanobelts had 
relatively larger drain currents but still on the order of nano-amps. This comparison reveals that 
the 2D PANI nanobelt maintains a good field-effect transistor. 
(a) (b) 
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4.5 CONCLUSIONS 
In conclusion, we presented a novel approach that combines top-down (nanofabrication) and 
bottom-up (chemistry) techniques to enable the simple and facile fabrication of PANI patterns 
with high throughput and uniformity. The chemical synthesis and subsequent lift-off process 
facilitate the mass production of PANI patterns on large areas. The lithography technique is not 
only capable of controlling the dimension of the PANI patterns but, also enables excellent 
uniformity seen in the shapes of the patterns. These PANI patterns also showed very good 
uniformity in their electrical properties. The FET studies on these PANI-NWs indicated that they 
are an excellent p-type material with an electrolyte-gate configuration. A proof-of-concept 
demonstration of this electrolyte-gate PANI-NWs FET sensor for the detection of CK-MB was 
also performed. This sensor showed very specific and rapid responses to the target with a very 
low detection level of 1 ng/mL. Importantly, the clinical cutoff level of CK-MB falls into the 
detection range of this sensor, demonstrating the potential use for clinical diagnosis. The method 
introduced here explores advantages of nanofabrication and chemical synthesis, and provides an 
easy way to produce hierarchical nanowires with controlled dimensions, and can potentially be 
applied to prepare other hierarchical nanostructures. 
The fabrication of 2D PANI nanobelts using a photolithography technique was achieved 
to reduce the cost for device manufacturing. These PANI nanobelts possessed excellent 
uniformity. The study of the morphology and topography of the nanobelts with SEM and AFM 
showed that these wires have very rough surfaces. As a result, the 2D PANI nanobelts are 
capable of providing large surface for the functionalization of antibodies. The resulting FET 
behavior of the 2D PANI nanobelts was similar to that of 1D PANI-NWs. Thus it is expected 
that the 2D PANI nanobelts would have comparable sensing performance to that of PANI-NWs. 
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5.0  ULTRASENSITIVE PANI FET SENSORS FOR BNP DIAGNOSIS 
5.1 INTRODUCTION 
B-type natriuretic peptide (BNP) is one of the most important cardiac markers for the prediction 
and diagnosis of heart failure.
74
 It is well-known that when a patient’s heart failure symptoms 
begin or worsen, the ventricles in the heart secrete BNP, causing an elevated level of the marker 
in the blood. In general, the greater the BNP level in the blood, the more severe the condition. 
The blood BNP concentration under normal conditions is ~20 pg/mL (6 pM), and it increases to 
~2 ng/mL (600 pM) for patients diagnosed with severe congestive heart failure.
154
 The BNP 
concentration is extremely low in blood, so conventional BNP detection techniques usually 
require expensive instruments such as a photomultiplier or excitation light source. Recently, 
electrochemical and optical biosensors were used to measure BNP. An electrochemical enzyme 
immunoassay was reported for the detection of BNP with a detection limit of about 20-40 
pg/mL, but the detection time took up to 2 hours.
73
 One year later, a surface plasma resonance 
sensor system was developed by the same group for BNP detection.
74
 While they reached a very 
low detection limit (~5 pg/mL), the SPR sensor requires sophisticated optical instruments which 
raises the cost for detection. Since it is suggested to monitor the BNP biomarker on a regular 
basis for those at an elevated risk of heart failure so that a negative event could be detected a 
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prior, biosensors that can detect trace levels of BNP in real time with a fast response and low 
cost are highly desired. 
In past decades, diverse electrical biosensing architectures have been developed such as 
amperomertric, conductometric, and field-effect transistor (FET) biosensors. Among them, FETs 
have generated much attention because they offer rapid and sensitive detection of the interaction 
events between the target biological molecules and the receptors on its surface.
30
 In a typical 
FET configuration, current flows along a semiconductor channel connected to the source and 
drain electrodes. The conductance of the semiconductor channel is tunable by controlling the 
bias on the gate electrode. In traditional complementary metal-oxide-semiconductor field-effect 
transistors (MOSFET), the conducting channel is implanted inside the bulk substrate and isolated 
from the gate electrode by a thin insulator layer. Conversely, in FET-based biosensors, the 
channel is in direct contact with the electrolyte or solution and that allows better control over the 
charges introduced onto the semiconducting channel surface. The net charges on the surface can 
change the surface potential on the semiconductor channel which can alter the channel 
conductance. This implies that FET-based biosensors might be very sensitive to the biological 
binding events on the channel surface. Therefore it is natural to expect that ultrahigh sensitivity 
of nanowire based biosensors could be achieved when the maximum effective charges on the 
channel surface and induced carrier density in the semiconductor channel are obtained.  
These scenarios can be realized when the ion/charge screening effects are well controlled. 
Ion/charge screening effects have been qualitatively studied in chemistry and physics. The 
research has concentrated on the influence of the screening mechanisms of dissolved ions in 
electrolyte and the carrier density in the semiconductor channel. It was found that the effective 
surface bound charges in an electrolyte solution can be significantly affected by the electrical 
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double layer formed by the ions.
[3]
 This effect has a significant impact on the sensing 
performance of FET biosensors and it is known as Debye screening on a certain length scale, 
termed as the Debye length (λD)
[3,4]
 in solutions. For aqueous solutions at room temperature, this 
length is given by 
   
 
√    ∑      
  (1) 
where λB is the Bjerrum length of the medium, and ρi and Zi are the density and the 
valence of the i-th ionic species.  Another screening effect in the semiconductor is known as 
Tomas-Fermi screening (also call Debye length in semiconductor, Tomas-Fermi screening is 
used to distinguish the Debye length in electrolyte) has strong effect on the induced carrier 
density. This Tomas-Fermi screening length LD is given by  
   √
     
    
  (2) 
where ε0 is the dielectric constant, kB is the Boltzmann's constant, T is the absolute temperature 
in kelvins, q is the elementary charge, and Nd is the density of dopants. 
In this chapter, the use of PANI FET biosensors for BNP detection in buffer solution and 
real samples are investigated. The sensor performances in sensitivity, dynamic detection range, 
and response time are evaluated. The sensing mechanism for the PANI FET sensors is studied as 
well. As the impacts of Debye-length to the PANI FET biosensor performance are investigated 
in details. The tuned PANI Debye length greatly improves sensor performance. In order to 
improve the PANI patterning quality and insulation, a bi-layer lithography pattern technique is 
introduced. Furthermore, an integrated biosensor system is developed based on the PANI FET 
sensors. The system is carefully evaluated with the tests of real BNP samples. 
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5.2 EXPERIMENTAL 
5.2.1 BNP Sensing Measurements 
The detections of BNP biomarker in phosphate buffer saline (PBS, pH=7.20) were investigated 
by using the PANI-NW FET microfluidic biosensors. A microfluidic chip containing PANI-NWs 
was placed on a probe station and connected to a semiconductor device analyzer (Agilent 
Technologies B1500A) through three probes. A probe was attached to the source, drain, and gate 
electrodes. The source-drain voltage and gate voltage were provided and controlled by the 
semiconductor device analyzer, which also collected the source-drain current during the 
measurements. For typical FET measurements, the Au electrodes connected to the NW were 
utilized as source and drain electrodes, another Au electrode was used as the gate electrode. A 
PBS solution was flowed into the microfluidic channel at first. In the meanwhile, the drain 
current (Id) of the NW was monitored by sweep the gate voltage (Vg) from 0.5 V to -0.5 V with a 
drain bias (Vd) of 0.5 V. Then another Id-Vg measurement was performed after  BNP solution was 
pumped into the microfluidic sensor. All the measurements were carried out at ambient 
conditions. For the BNP detections in whole blood samples, the BNP purchased from Sigma-
Aldrich was spiked in normal human blood. The normal human blood was provided by the 
UPMC Cardiovascular Institute. An identical setup and method were used in the BNP detection 
in PBS solutions, however, the applied drain and gate voltages were altered. 
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5.2.2 Sensing Mechanism Measurement 
Two PBS solutions with different pHs (7.2 and 4.75) were used for the study of the detection 
mechanism of PANI-NWs FET sensors. The same measurement procedure as the BNP detection 
was used. All the tests were taken in ambient conditions. 
5.2.3 Debye-Length Tests 
To investigate the effect of Debye length to the detection of BNP using our NW-FET sensor, the 
measurements were performed in dilutions of PBS. These dilutions were made relative to 1x 
PBS, which contains 150 mM NaCl, 3 mM KCl, and 10 mM phosphate salts. The calculated 
values of λD for the five diluted solutions 1x, 0.5x, 0.25x, 0.1x, and 0.05x PBS are 0.7 nm, 1.04 
nm, 1.47 nm, 2.3 nm, and 3.3 nm, respectively. The NW-FET sensors were functionalized with a 
BNP aptamer. For the NW-FET measurements, the Au electrode pair connected with the NW 
was used as source and drain electrodes and another Au electrode was employed as the gate 
electrode. The drain current (Id) was monitored by sweeping the drain voltage (Vd) from -1 V to 1 
V with a gate bias of -0.25 V. The measurements were performed at ambient conditions. 
5.2.4 2D PANI Nanobelts for BNP Sensing 
A single chip containing 12 PANI nanobelts cut from a 4 inch wafer was shown in figure 5.1. A 
microfluidic replica with two microfluidic channels was placed on the chip with strong adhesion 
to seal the microfluidic and the chip. This completed the microfluidic sensor fabrication. The 
tests of the BNP detection using a potentiostat based biosensor system were carried out in 
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ambient conditions. The PANI belts were functionalized with BNP antibodies. And then 0.1x 
PBS, BNP in PBS with different concentrations, and nonspecific targets (Myo, CK-MB, etc.) 
solutions were used for the drain potential sweeping tests and the gate bias.  
 
Figure 5.1. Microscopy Images of a 2D PANI nanobelts patterned chip and a microfluidic integrated 
sensor chip.  
5.3 RESULTS AND DISCUSSIONS 
5.3.1 BNP Detections in Buffer Solution 
The BNP aptamers functionalized PANI-NWs were employed for the detection of BNP for 
demonstration. Figure 5.2 shows the real-time measurement of normalized responses (Id/Id0) 
from the surface modified PANI-NWs FET sensors responding to BNP with increasing 
concentration in PBS solutions. The specificity of the PANI-NWs was tested by introducing a 
100 ng/mL bovine serum albumin (BSA) in PBS solution to the FET sensor. No significant 
change was observed from the curve shown in figure 5.2. In contrast, when BNP solutions were 
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added to the FET sensors, considerable changes were observed. These results indicate that the 
FET sensor has a very good specificity.  
 
Figure 5.2. Real-time detection of BNP with increasing concentration in PBS solution using PANI-NWs 
FET biosensors (Vg=-0.5 V, Vd=0.5 V). 
The binding of BNP through the strong interaction between BNP and its aptamer on the 
surface of the PANI-NWs resulted in the increase of Id. The drain current began to increase right 
after the addition of BNP and rapidly reached a stable value within 1 minute. The lowest BNP 
concentration of 25 fg/mL was detected with a ~10% increase in Id. When the BNP concentration 
was progressively increased to 100 fg/mL, 500 fg/mL, 1 pg/mL, and 5 pg/mL, consistent 
increases in Id of ~17%, ~22%, ~28%, and ~32% were observed respectively. 
Figure 5.3a shows the typical plot of the drain-source current versus gate voltage of the 
PANI-NWs FET in PBS buffer solution. The drain current Id rises upon increasing negative Vg at 
positive drain-source voltage (Vd), indicating a p-type behavior of the PANI-NWs FET devices. 
Upon the addition of a high concentration of the nonspecific target molecule BSA, no Id changes 
were observed, while the sensor showed significant increase in Id upon the addition of BNP 
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solutions, indicating the good specificity of this sensor. When the BNP concentration was 
progressively increased, consistent increases in Id were also observed. 
 
Figure 5.3. (a) Id-Vg curves of the PANI-NWs to different solutions. It is clear that the sensor shwoed 
nearly non response to the non-specific target, but significant changes to BNP targets referring to the PBS 
background. (b) Plot of BNP concentration versus the current change, the data were collceted forn three samples for 
each concentration. 
Figure 5.3b shows the plot of normalized changes of drain current as a function of the 
BNP concentration. The PANI-NWs exhibited a wide dynamic sensing range from 25 fg/mL to 
5pg/mL. The lowest detectable BNP concentration of 25 fg/mL is much lower than that obtained 
by the surface plasma resonance sensor (5 pg/mL). This ultrahigh sensitivity and low detection 
limit can be ascribed to the unique concaved-shape of the PANI-NWs. First of all, the high 
surface area of the PANI-NWs can provide abundant active binding sites for the target molecule. 
Secondly, the concave-shaped PANI-NWs allow a higher portion of the volume of the NW to 
contribute to the signal change than conventional NWs, thus utilizing the high surface area to 
volume ratio. 
(a) (b) 
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5.3.2 BNP Detections in Real Samples 
The use of the PANI-NWs FET sensors for detection of BNP in real samples was evaluated by 
measuring different BNP concentrations in human blood serum. Due to the property differences 
between the serum and PBS solution (e.g., salt concentrations, viscosity, and dielectric constant), 
the sensitivity and detection limit of the sensor can be affected. In these tests, to eliminate the 
influence of the salt concentration, instead of using PBS buffer solution as background, serum 
solution containing no BNP molecules was employed as the background baseline reference. The 
FET tests results were plotted in figure 5.4. It can be clearly observed that the drain current for 
the 1 pg/mL BNP serum solution was higher than the one for the serum solution. The current 
change at Vg=-0.4 V was about 18.8%. The same change was found for higher BNP 
concentration, which had a bigger change (~24.3%) on the drain current as well.  
 
Figure 5.4. Typical Id-Vg curves of PANI NW FET sensors in responding to BNP in serum solutions. Drain 
voltage was set as 0.4 V. The changes in the drain curent for (a) 1 pg/mL and (b) 5 pg/mL BNP are about ~18.8% 
and ~24.3%. All the measurements were performed in ambient conditions. 
(a) (b) 
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Serum samples with different BNP concentrations were tested to study the relationship 
between the BNP concentration and the sensor response. The PANI-NWs FET sensors showed 
~4% increase in Id at the BNP concentration of 100 fg/mL. Despite the reduced sensitivity 
compared to that obtained in the PBS solution, distinguishable changes in the FET sensors were 
observed over a wide range from 100 fg/mL to 5 pg/mL as shown in figure 5.5. This 
demonstrates the applicability of the PANI-NWs FET sensors for the monitoring of BNP in real 
serum samples on a regular basis, which requires the detection of blood BNP at levels below 
normal conditions (20 pg/mL). 
 
Figure 5.5. Normalized drain current change of the NW FET sensors as a function of BNP concentration 
with respect to the baseline in PBS solution. 
For further study, the BNP purchased from Sigma-Aldrich was spiked in normal human 
blood. The normal human blood was provided by the UPMC Cardiovascular Institute. The same 
setup and method used in the BNP detection in PBS solution were also employed for these tests 
except the applied drain and gate voltages were altered. The Id-Vg curves of the PANI-NW FET 
sensors responding to whole blood samples are shown in figure 5.6a and b. It is clearly shown in 
the figures that the Id of the NWwas decreased (~-18.5%) after the addition of a whole blood. 
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This is due to the high viscosity and ionic concentrations in whole blood. When a BNP (100 
pg/mL) whole blood sample was added onto the sensor, it showed an increased Id (~22.3%). The 
negative effect on the NW caused by the whole blood was counteracted by the addition of BNP 
because the binding of negatively charged BNP resulted in positive current changes in the NW.  
 
Figure 5.6. Id-Vg curves of PANI NW FET sensors responding to health whole blood control sample (a) 
and whole blood sample (b) containing 100 pg/mL BNP. 
 
 
Figure 5.7. Normalized drain current change of the NW FET sensors as a function of BNP blood 
concentration referring to the baseline in PBS solution. 
(a) (b) 
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The change in the normalized drain current of the PANI-NW FET sensors as a function 
of BNP blood concentration is given in figure 5.7. As shown in the graph, a positive response of 
the NW was shown when the BNP concentration was higher than 5 pg/mL. More positive current 
changes can be observed as the BNP concentration is increased from 5 pg/mL to 1 ng/mL. These 
results indicate the feasibility of using the PANI NW FET biosensor to detect BNP biomarkers in 
whole blood. 
5.3.3 FET Sensing Mechanism 
The mechanism behind change in current upon binding of target molecules can be explained by 
the gating effect of surface charges carried by the target molecules. Because the isoelectric point 
(pI) of BNP used in this experiment is ~5.4, the BNP molecules are negatively charged in PBS 
solution that has a pH of 7.20. Therefore, the negative surface charges introduced by the specific 
binding between BNP and its receptor would lead to the carrier accumulation in PANI-NWs, 
causing an increase in drain current. According to this principle, the drain current of the PANI-
NWs would decrease if positively charged target molecules are captured by the aptamers on the 
surface of PANI-NWs.  
To verify this, a PBS solution with a pH of 4.75 containing 1 pg/mL BNP was added to 
the PANI-NWs FET sensor. As shown in figure 5.8, a decrease in Id is observed upon the 
addition of this PBS solution, in which the BNP molecules are positively charged. Hence the 
current response is believed to be attributed to the surface charge gating effect introduced by the 
specific binding. Interestingly, compared with the current change (~28%) of 1 pg/mL BNP in pH 
7.20 PBS solution, the PANI-NWs showed a ~10% change in Id when the pH of PBS solution 
decreased to 4.75. The possible reason is that the number of charges carried by a BNP molecule 
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in pH 7.20 PBS solutions is more than that in pH 4.75 PBS solution due to the larger difference 
between the pH and the pI of BNP in former solution than that in the latter one. 
 
Figure 5.8. (a) The detection of BNP in PBS solutions with different pH and (b) the biosensing 
mechanism.  
(a) 
(b) 
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5.3.4 Debye-Length Investigation 
Traditional conductometric nanowire biosensors that only use two electrodes to measure the 
nanowire conductance/resistance changes have a poor sensitivity and high detection limit when 
compared to the nanowire field effect transistor (NW-FET) biosensors because the additional 
gate modulation in NW-FETs can amplify detection signals. Specifically the charges introduced 
by the captured molecules on the surface of NW-FETs can induce a gating effect on the NW,
128, 
155
 resulting in the accumulation or depletion of carriers in the NW. While in ionic solution, the 
electrical double layer formed by the ions can reduce the effective charges of the bound 
molecules.
156
 This effect has a significant impact on the sensing performance of the biosensor 
and it is known as Debye screening and is shown in figure 5.9, termed as the Debye length 
(λD).
156, 157
 For aqueous solutions at room temperature, this length is given by 
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where lB is the Bjerrum length, and ρi and Zi are the density and the valence of the i-th 
ionic species. The solution Debye length strongly affects the gating effect for NW-FET 
biosensors. The study of Debye screening and Debye length engineering thus is critical to 
improve the NW-FET sensors’ performance. 
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Figure 5.9. Illustration of the Debye screening length in solution. Within shorter Debye length, more of the 
charges carried by the target molecules will be screened by counter-ion. 
At the same time, the Debye length of semiconductors (figure 5.10) also has a very 
significant influence on the FET sensor behavior too. The Debye length of semiconductors is 
also known as the Thomas-Fermi screening length. The electrical field generated by the surface 
charges can penetrate the semiconductor surface up to a distance that is equal to the Thomas-
Femi screening length. Hence only a portion of the semiconductor is affected by the surface 
charges when the Thomas-Fermi screening length of the semiconductor is shorter than the radius 
of a cylinder semiconductor. This implies that the Thomas-Fermi screening length of a 
semiconductor can strongly impact the FET sensor performance. The Thomas-Fermi screening 
length of semiconductors is given by: 
   √
    
    
 
Where ε is the dielectric constant, KB is the Boltzmann's constant, T is the absolute 
temperature in kelvin, q is the elementary charge, and Nd is the density of dopants (either donors 
or acceptors). 
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Figure 5.10. Illustration of the Thomas-Fermi screening length of a nanowire, which is dependent on the 
carrier concentration in the NW. 
To study the impact of the solution Debye length to the sensor performance, five PBS 
dilutions were tested for the BNP detection. For a typical measurement, the Id of the sensor 
versus the drain voltage (Vd) in PBS dilutions (pH=7.4) was established first. Then the same PBS 
solution containing 10 pg/mL BNP was added to the sensor. The binding of BNP, a negatively 
charged peptide with an isoelectric point (pI) of ~5.42,
158
 to the sensor resulted in an increased Id 
of the p-type device. Multiple tests were performed on the sensor using different PBS dilutions. 
As shown in figure 5.11a, larger Id changes can be observed in 0.05x PBS than that in 0.5x PBS. 
For instance, the Id changes of the NW-FET sensor in 0.05x and 0.5x PBS were 15.7 nA and 
10.9 nA at Vd=0.7 V. The ionic strengths of 0.05x and 0.5x PBS solutions yielded Debye lengths 
of 3.3 nm and 1.04 nm, respectively. Because of the larger λD in 0.05x PBS, more charges 
carried by the BNP molecules were effective in altering the conductivity of the NW, resulting in 
a larger Id changes. Figure 5.11b shows the Id changes of the NW versus the solution Debye 
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length at Vd=0.7 V and Vg=-0.25 V. An exponential increase in Id can be observed as the Debye 
screen length increases. The theoretical nonlinear fit of the device Id corresponds to the Debye 
length which is also shown (dash line). The estimated maximum Id change is ~20 nA, and the 
average distance of the bound charges to the NW surface is ~1.4 nm.  
 
Figure 5.11. (a) Id-Vd curves of a NW-FET sensor in different PBS dilutions. (b) Drain current change as a 
function of solution Debye length, and the theoretical fit of current change versus Debye length. Within shorter 
Debye length, more of the charges carried by the target molecules will be screened by counterions. 
Our previous investigation indicates that the Debye screening had a strong impact on the 
sensing performance of our FET biosensors. Our experimental data matches the theoretical fit 
very well. Hence the Debye length should be engineered to obtain optimal performance for the 
NW-FET biosensor. Although the NW-FET biosensor can be utilized to detect BNP in normal 
blood or patients’ serum as demonstrated previously, the tests were not performed with an 
optimized solution Debye length either in normal blood or patients’ serum due to their high salts 
concentrations. Hence the engineering of Debye length in untreated blood or serum samples that 
contain high ions concentration still poses challenges. 
In general, the performance of NW-FET sensors are impacted and determined by three 
major factors: (1) the ions concentrations in blood/serum, (2) the net charges carried by the target 
molecules, and (3) the carrier concentration in the NW. The ion concentration in blood/serum 
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determines the solution Debye length, beyond which the gating effect from the bound charges to 
the NW would be screened out. The net charge carried by the target molecules is dependent on 
its pI and the blood/serum pH, which determines the accumulation or depletion of carriers on the 
NW surface. The carrier concentration in the NW can be controlled by the gate bias, which has a 
great impact on the amount of current change.  
Our previous studies on the solution Debye length reveal that the solution Debye length 
has a significant impact on the NW-FET sensor performance. By diluting the buffer solution, 
which reduces the solution ionic strength, larger solution Debye lengths can be obtained. Those 
large Debye lengths could increase the effectiveness of charges that are bound to the NW, 
generating more current changes. However, ion concentrations are high (> 100 mM) and the pH 
in blood/serum is fixed, giving a short solution Debye length (<0.7 nm) and defined net charges 
of the target molecules. As a result, the direct detection of biomolecules in untreated blood/serum 
is severely hampered by the Debye screening effects.  
Recent studies have demonstrated that the sensing performance of NW-FET sensors can 
be exponentially enhanced in the sub-threshold regime because the reduced screening of carriers 
in the NW promises the most effective gating effect from the charges bound on the NW 
surface.
128
 For NW-FET sensors, it is more meaningful to characterize the sensor by the 
dimensionless parameter, ΔI/I0, which relates the volume of the NW gated by surface charges 
(represented by ΔI) to volume of the whole NW (represented by I0). Therefore, ΔI/I0 should reach 
maximum when the NW is fully utilized, which happens when the sensor is near carrier 
depletion.
128
 This finding thus inspires us to engineer the Debye length of the NW to improve its 
sensing performance. 
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As introduced before, the Debye length of the NW (Thomas-Fermi screening length) is 
determined by the carrier concentration in the NW. For high carrier concentration in NW, the 
screening length is shorter. Thus, the charged molecules bound on surface can only gate the NW 
within a thin surface layer, producing small current changes in the NW. To achieve large current 
changes, a long Debye length (low carrier concentration) is required, which can be obtained at 
the sub-threshold region of the NW. The sub-threshold region is where the minority carriers 
present under the gate when the gate voltage is less than the threshold voltage. These carriers 
cannot be totally neglected, and play an important role in device and circuit performance. The 
current originated from these carriers can be addressed using a capacitor model. An illustration 
of the model is shown in figure 5.12. 
 
 
Figure 5.12. An illustration of the capacitor model for the sub-threshold region current. 
According to the model,  
   
   
   
 
   
  
  ⁄   , where γ is the body effect parameter 
               ⁄   , where η is the capacitive coupling 
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While in the linear region, the drain current can be expressed as: 
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Where Vref represent the contribution of reference electrode 
            χsol is the surface dipole potential of the solvent 
           Φs is the semiconductor work function. 
Therefore,  
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From equation (1) and (2), the current change in the sub-threshold region increases 
exponentially, relative to the surface potential changes, while in linear region. Therefore, the 
largest change can be achieved in the sub-threshold region. 
The sub-threshold regime of the NW can be observed from its Id-Vg characterization. 
Then the optimum gate bias can be found from the BNP measurements in blood/serum. The 
optimal Debye length in the NW can then be engineered with this optimum gate bias, and the 
highest volume ratio between the part of the NW gated by surface charges and the whole body of 
the NW could be obtained. This setup with the engineered NW Debye length is expected to 
achieve the highest current change and lowest detection limit of the sensor in blood/serum. 
Determining the sub-threshold region from a typical Id-Vg curve is simple and 
straightforward. As shown in figure 5.13, the sub-threshold is in the region where the gate 
voltage is less than the threshold voltage. In this region an exponential increasing current can be 
observed. The Id-Vg curves of a PANI-NW are shown in figure 5.13b for normal (blue) and 
logarithmic (red) scales. The drain current was off until the gate voltage was less than -0.6 V, 
after which the current increased exponentially. When the gate voltage was less than -0.7 V, the 
drain current followed a linear change. Where the drain current showed an exponential change in 
the region is described as the sub-threshold region. In this I-V curve, the sub-threshold region for 
the PANI-NW was found in between 0.6-0.7 V. 
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Figure 5.13. The sub-threshold region of FET devices. (a) Definition of sub-threshold region. (b) Plot of 
the I-V curve of PANI-NW, in which the sub-threshold region was found within 0.6-0.7 V.  
The tests of BNP modified PANI-NWs with an optimized gate bias were performed to 
achieve the optimal sensing response. Similar tests method for BNP detection was used and the 
gate bias was swept from 0.5 to -1.5 V. Serum with no BNP was used as the blank background 
and reference. The responses of the PANI-NWs in drain currents to BNP solutions were 
gradually increased as the BNP concentration increased from 0.5 to 5 pg/mL. The drain current 
changes of the sensor were calculated at the PANI-NW sub-threshold region (Vg=-0.6 V) and the 
saturation region (Vg=-1.5 V), and the comparison of the responses from the NW is given in the 
table. The current change of the sensor to 0.5 pg/mL BNP was ~73.3% at its sub-threshold 
region, which is about 5 times greater than that at its saturation region (~15.9%). The same 
phenomena were observed for higher BNP concentration and the results are shown in figure 
5.14. These results clearly showed that the sub-threshold region of the sensor was more sensitive 
than the liner or saturation region of the sensor, which matches the sub-threshold theory.  
(a) (b) 
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Figure 5.14. (a) Id-Vg curves of BNP modified PANI-NW responding to BNP targets. In the sub-threshold 
region, the NW showed greater changes than that in linear and saturation region. (b) Comparison of the changes in 
sub-threshold region and saturation region. 
5.3.5 Biosensor System 
In order to build a biosensor platform with convenient interconnects for data acquisition, the 
sensor chip connectors were redesigned. Two different sockets were anchored on a PCB board so 
that the connectors are compatible to two different sensor chip layouts. One kind of layout 
requires wire-bonding to connect the sensor device to the measuring instrument. The other 
device layout does not require any wire-bonding steps, and the device can be directly inserted 
into the socket to connect to the measuring instrument (figure 5.15). The pads on a sensor chip 
were connected to an outlet socket, thus only few copper wires were needed to switch the sensors 
during measurements.  
The microfluidic component contained a syringe pump, a multi-inlet microfluidic chip, 
and the microfluidic channel for sensors. The fluidic flow rate was controlled by the syringe 
pump with both withdraw and inject modes. The multiple-inlet microfluidic chip was employed 
(a) (b) 
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because multiple solutions were expected to flow into the microfluidic channel. The chip has five 
inlets for five different solutions at each test. The PDMS microfluidic replica was attached to the 
sensor chip so that the microfluidic channels covered the PANI-NW sensors. The outlet of the 
channel was connected to the syringe pump so that the solution could be withdrawn from the 
solution container, passing through the multiple-inlet chip and flow through the sensing area 
during the measurements. 
 
Figure 5.15. The redesigned sensor measurement system including multiple sample inlets, syringe pump, 
and chip sockets board that compatible to two different chip layouts. The whole system simplified the component 
assembly steps.  
The BNP detection tests were also performed using the redesigned sensor system. The 
biosensor chip integrated with the microfluidic channel was placed in a socket and connected to 
the PCB board. For the measurements, the gate bias was swept from 1 V to -1.2 V at a constant 
drain voltage of 0.4 V. The solutions were sequentially flowed into the microfluidic channel and 
the data were shown in figure 5.16. No notable responses were observed in the PANI-NW for the 
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nonspecific targets when compared to the base response obtained with PBS. However, 
significant changes in drain current were seen for BNP solutions. This preliminary result 
demonstrated that the biosensor system has the capability to perform ultrasensitive biomolecule 
detections. 
 
Figure 5.16. Several tests for a PANI-NW using the rebuilt measurement system.   
To establish a portable biosensor platform, the previous design was adapted to be 
compatible with a potentiostat. There are many portable potentiostat instruments available in the 
market, thus the demonstration of this potentiostat based biosensor platform would suggest the 
potential for the future development of a portable biosensor system. The circuit and microfluidic 
design were kept the same, but an additional power supply was added to provide the gate bias. In 
order to control the power supply by a desktop, a bias control software user interface was built 
using Labview. The whole system is shown in figure 5.17. A very important improvement for 
this system is that the sensor chip was redesigned so that the chip could be inserted into the 
socket directly and no wire-bonding steps are required. This feature ensures good contact 
between the socket and the chip and reduces the process steps for wire-bonding.  
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Figure 5.17. The latest sensor measurement system adapted from the previous system including multiple 
sample inlets, a syringe pump, and a chip sockets, a gate bias power supply, a potentiostat, and a data acquisition 
system. The whole system illustrated the potential for a portable biosensor system.  
5.3.6 Biosensor System Evaluations 
To find out the optimal parameters for the test, the effect of the drain voltage sweeping rate, and 
the applied gate bias were investigated. In electrochemistry, the peak current is proportional to 
the square root of the sweep rate, thus it is expected that different drain voltage sweeping rates 
would lead to different drain currents. The drain voltage sweeping tests were carried out using 
the biosensor system built previously at four different sweeping rates (0.01, 0.05, 0.1, 0.5 V/s). 
The results are shown in figure 5.18.  
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Figure 5.18. The drain voltage sweeping rate for the measurements: (a) 0.01 V/s, (b) 0.05 V/s, (c) 0.1 V/s, 
(a) 0.5 V/s. 
As mentioned before, the peak current is proportional to the square root of the sweeping 
rate. The drain current for the sweeping rate at 0.05 and 0.10 V/s were about 440 pA and 600 pA 
when the drain potential was 0.4 V in PBS. The ratio between these two current was about 1.4, 
which is the square root of the sweeping ratio. In addition, small drain current was observed for 
slow sweeping rate and larger currents were found for fast sweeping. While for the 0.5 V/s 
sweeping rate, it had limited sampling points, thus the I-V curve was not smooth. For the other 
three sweeping rate, the I-V curves were very smooth. For a very fast detection, the sweeping 
rate of 0.1 V/s only required 4s for a measurement, therefore the drain potential sweeping rate 
were set as 0.1 V/s for the rest tests. 
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Figure 5.19. Different gate bias (a) 0, (b) -0.1, (c) -0.3, (d) -0.5, (e) -1.0, and (f) -1.5 were applied to find 
out the optiaml gate bias conditions for the sensing test. 
The gate bias also has very crucial impact on the measured responses. To find out the 
optimal gate bias for the potentiostat biosensor system, several gate biases were used for the 
measurements. The sweeping of the gate bias for the tests was not applicable due to that the 
power supply can only generate fixed output. In this study, six gate biases 0, -0.1, -0.3, -0.5, -1.0, 
-1.5 V were tested, and the results are shown in figure 5.19. Since the PANI nanobelts are typical 
p-type material in PBS solution, as the gate bias went to more negative, higher drain currents 
were obtained. For example, the source-drain current at 0 V gate bias was ~-700 pA for the 
target, and the current for -1.5 V gate bias was ~-6 nA. But in the meanwhile, the current for the 
background and the non-specific cardiac biomarkers (Myo, CK-MB) were also amplified, 
leading to relatively less sensitive and specific responses for the PANI nanobelts to the target 
BNP molecules. According to these results, the gate bias of 0 V was selected for the rest tests. 
In previous study, the optimal measuring conditions were found for the tests. Then the 
tests of BNP biomarker concentrations versus the drain current changes with the optimized 
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conditions were performed for the further evaluation of this potentiostat based biosensor system. 
The specificity of the biosensor was examined using the system, and the results are shown in 
figure 5.20. For non-specific cardiac biomarkers, e.g. Myo, cTni, and CK-MB, the BNP sensor 
showed nearly non-response referring to the background in PBS solution despite that the 
concentration of these non-specific biomarkers were very high. However, when the BNP 
biomarker was added to the sensor, an obvious drain current increase was observed. This result 
revealed that the biosensor was able to specifically recognize the target.  More importantly, as 
the BNP concentration increased from 50 pg/mL to 1000 pg/mL, the drain current increased 
accordingly as shown in figure 5.20b. Since the test results would be influenced by many factors 
both by the sensor itself and the test environments, hence to gain results with high confidence, 20 
devices were tested. These devices were tested with all the five BNP concentrations and the 
results are given in table 2. The response changes were calculated referring to the device 
responses in PBS background. These results showed large range variations, therefore, a statistic 
data processing method was used to reduce the variations and errors. 
 
Figure 5.20. (a) Specificity tests of the sensor device using the potentiostat biosensor system. (b) A 
example of the sensor responses to different BNP concentrations. 
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Table 5.1. Test data of 20 sensor devices response to different BNP concentrations. 
 
50 100 200 500 1000
1 11% 21% 62% 97% 140%
2 13% 18% 37% 80% 102%
3 16% 49% 70% 84% 90%
4 17% 34% 83% 120% 138%
5 17% 40% 76% 95% 110%
6 19% 50% 82% 101% 112%
7 21% 32% 38% 60% 77%
8 24% 33% 38% 61% 78%
9 25% 54% 81% 84% 118%
10 25% 28% 70% 116% 139%
11 25% 34% 46% 63% 81%
12 25% 29% 34% 61% 71%
13 25% 43% 74% 86% 93%
14 27% 41% 56% 70% 74%
15 28% 45% 63% 74% 81%
16 29% 48% 61% 78% 82%
17 31% 60% 91% 118% 131%
18 33% 36% 57% 67% 79%
19 34% 52% 83% 105% 133%
20 39% 75% 94% 122% 130%
Mean 24% 41% 65% 87% 103%
Sigma 7% 14% 19% 21% 25%
Summary
Device #
BNP Concentration (pg/mL)
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Figure 5.21. (a) An example of statistic data analysis of the data obtained from 20 sensor devices for 50 
pg/mL BNP. The figure showed the results distribution, the mean, the standard deviation, and 80% confidence 
interval. (b) Statistic results of the 20 sensor devices test results. 
Table 5.2. The statistic data calculated from 20 devices for different BNP concentrations. 
 
Lower Upper
50 24.2% 7.3% 23.3% 25.8%
100 41.1% 13.6% 34.2% 46.1%
200 64.8% 19.0% 59.7% 74.8%
500 87.2% 21.1% 76.9% 95.8%
1000 102.9% 25.2% 81.4% 113.8%
80% Confidence Interval
BNP Conc. (pg/mL) Mean Sigma
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The test data of 20 samples were statistically processed to eliminate errors from the tests. 
For example, in figure 5.21 the normal distribution plot of the data for 50 pg/mL BNP showed 
the distribution of the data from the minimum to the maximum test results. It also calculated the 
mean and standard derivation for the tests, and the 80% confidence intervals for both mean and 
median. All the data for different BNP concentrations were statistically analyzed and the results 
were plot in figure 5.21b. The horizontal bars are the mean of each point and the vertical bars 
show the response ranges for each point with 80% confidence. It can be clearly observed from 
the figure, the sensors had a linear detection range from 50 to 200 pg/mL. And the sensors 
became saturated for higher concentrations, e.g. 1000 pg/mL. The detailed drain current changes 
and the corresponding 80% confidence intervals for these concentrations are listed in table 5.2. 
This test results are comparable with the results obtained from the PANI-NWs. 
The shelf-life of the functionalized biosensor is an important parameter for the device. In 
fact, the device shelf-life is mainly determined by the biomolecules modified on the surface of 
the PANI nanobelts. Typically, the antibodies are very sensitive to the environmental change, 
and the degradation or deactivation of the antibodies can be caused by temperature, the 
atmosphere, and the salt concentration. Hence to maintain the bioactivity of the antibodies, the 
functionalized devices were kept in 4 °C for the tests. For the same device, the response at day 1 
was ~33% to 100 ng/mL BNP in PBS solution, and the response decreased to ~20% and ~14% at 
day 7 and 14 (figure 5.22). This response reduce was believed due to the deactivation of the 
antibodies modified on the PANI surface as the increasing storage time.   
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Figure 5.22. The reliability tests for the BNP sensors for two weeks. The sensor responses decreased about 
50% in 14 days. 
The test of BNP in buffer solution confirmed that the biosensor system has very sensitive 
responses to the target. While it is highly desired to monitor the BNP in the human bloods or 
serums, hence the blind tests of blood samples with unknown BNP concentrations were carried 
out using the biosensor system with 2D PANI nanobelts. The measurement parameters were set 
the same as that used in previous tests. The serum samples were collected from different patient 
with different health conditions. For example, as shown in figure 5.23, different serum samples 
from human and pig were tested with different devices. From the tests results in figure 5.23a, the 
normal sample always showed the lowest responses, the SE sample showed the biggest responses.  
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Figure 5.23. The blind tests for blood samples (a) human and (b) pig using the 2D PANI nanobelts FET 
sensors. The biosensor system is capable of detecting biomarkers in serum samples.  
According to these results, the normal sample has the lowest BNP concentration. 
Comparing to the normal sample, the SE samples showed about 58.7% higher responses in 
average from three different devices. This is confirmed by ELISA test results of that the BNP 
concentration was ~126 pg/mL for SE sample. The normal sample has normal BNP level. For 
the pig serum, the tests results were opposite to that from the ELISA tests. However it showed 
different responses to different pig BNP levels. Studies on the pig BNP molecule structure and 
the using it specific BNP antibody would possibly address this issue. In short, these preliminary 
test results indicate that this sensor system has the ability to test real samples, and reliable results 
can be obtained with statistics analysis from more tests. 
5.4 CONCLUSIONS  
The PANI-NWs FET biosensors were found very sensitive to the BNP target in buffer solution. 
When the BNP concentration was progressively increased to 100 fg/mL, 500 fg/mL, 1 pg/mL, 
Pig Human 
(a) (b) 
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and 5 pg/mL, the sensors showed consistent increases in Id of ~17%, ~22%, ~28%, and ~32% 
respectively. These sensors also exhibited a wide dynamic sensing range from 25 fg/mL to 
5pg/mL. The lowest detectable BNP concentration of 25 fg/mL is much lower than that obtained 
by surface plasma resonance sensor (5 pg/mL). The performance of this FET biosensor for serum 
samples were studies as well. The PANI-NWs FET sensors showed ~4% increase in Id at the 
BNP concentration of 100 fg/mL in serum. Despite the reduced sensitivity compared to that 
obtained in PBS solution due to the high salt concentration in serum, distinguishable changes in 
the FET sensors were observed over a wide range from 100 fg/mL to 5 pg/mL. The test results 
found in whole blood still showed that this FET biosensor is capable of detecting BNP in whole 
blood although the signals were not as good as that in buffer or serum solution. The study of the 
detection mechanism reveals that the signal changes of this FET biosenor is due to the gating 
effect introduced by the net charges on target molecules. 
 The improvement on the PANI-NWs patterning using bi-layer photoresist process 
achieved better PANI-NW shape uniformity and better insulation among electrodes, thus allowed 
better sensor performance. Significantly, the investigation on the Debye length opened an 
approach to further improve the sensitivity of the biosensor. An optimal Debye length of the wire 
can be obtained by tuning the gate bias. Within the sub-threshold region of the NW, the sensor 
showed about 4 times increase in the response comparing to that in the linear region of the wire.  
In order to further reduce the cost for the sensor fabrication, instead of using E-beam 
lithography, photolithography was used to pattern PANI nanobelts on the sensor chip. A 
biosensor system was as built for sensor tests, which contains a sensor component, a microfluidic 
part, a potentiostat, and a data acquisition sub-unit. The study regarding to the potential sweeping 
rate and gate bias reveals that the optimal sweeping rate was 0.1 V/s and the gate bias was 0 V 
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for the system. The statistical analysis of the test results from 20 sensor device using the 
biosensor system demonstrated that the sensors have a linear dynamic response range for BNP 
from 50 to 200 pg/mL. Those findings verified that the 2D PANI nanobelts possess comparable 
sensing performance with PANI-NWs. The demonstration of BNP test in serum samples using 
this system showed that the sensor devices can clearly determine different BNP concentration 
levels. These results suggested a great potential of this BNP sensing system for clinical use in 
future.  
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6.0  SUMMARY AND FUTURE WORK 
The work present here includes significant advances in the understanding and developing of 
ultra-sensitive field-effect transistor biosensors for the monitoring and diagnosis of biomarkers. 
The understanding of the FET biosensor behaviors in fundamental helped to achieve optimal 
sensor performances in terms of sensitivity and detection limit. The sensor uniformity and 
reliability were greatly improved by introducing a well-controlled sensor fabrication method. 
These improvements facilitate the realization of an improved biosensor system incorporated with 
the sensor component, microfluidic unit, and data acquisition sub-system.   
The incorporation of functionalized nanowires with a microfluidic unit was challenging 
since the typically microfluidic integration requires O2 plasma treatment that potentially would 
deactivate the surface modified nanowires. To address this, a shadow mask was introduced to 
protect the nanowire sensors when perform the plasma treatments. The work concentrated on this 
aspect confirmed that the shadow mask was capable of preventing damages to the nanowires, 
hence ensured the bioactivity of the sensors after incorporated with microfluidics. 
This research work provides an alternative polymer sensors fabrication method that 
combined with micro-fabrication techniques and chemical synthesis approach to prepare sensors 
with high uniformity and high yield on wafer scale. This promised the improvement on the 
reliability of the sensor tests. A three electrodes field effect transistor biosensor configuration 
with a liquid gate was studied for the monitoring of biomarkers in both buffer and serum 
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samples. The findings in this study verified that the nanowire sensors were capable of detecting 
the target even its concentration was very low. The investigation on the fundamental of the 
Debye length of semiconductor and sub-threshold region revealed that a great improvement of 
the sensor performance can be achieved with optimal test conditions. This study allowed the 
development of ultra-sensitive biosensors. In addition, to reduce the cost for sensor fabrication, a 
photolithography technique was introduced to replace the E-beam lithography process. This 
change allowed a great deal of reduction in time and cost. The 2D PANI nanobelts were found 
having comparable sensing performance with the 1D PANI NWs. 
A sophisticated biosensor system was built in this research for the monitoring of a 
cardiovascular biomarker, BNP, based on the biosensors and microfluidics. The system was 
utilized to measure BNP in both buffer solution and serum samples. The results suggested that 
the system can be potentially applied for clinic use and adapted into a portable biosensor system 
in future.  
Since the biosensor system was designed for real use to measure low concentrated 
biomarkers in human body fluid like blood, the future works for this study would be focused on 
more tests of patient blood samples and further improvement on the tests reliability. It is 
challenging because the complicated compositions and the high salt concentration in human 
blood. These difficulties would lead to unsuccessful detection and diagnosis of BNP level in 
these samples. To reduce these effects from human blood, the sensor measuring parameters need 
to be optimized so that the sensor can be operated at the optimal conditions. Such as the further 
optimize the gate bias for the sensors to achieve long Debye length in the semiconductor, which 
can lead to very sensitive responses to the target and reduce the noise from non-specific targets. 
Furthermore, the tests in this work were done in a steady environment. It is of interest that to test 
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the sensor in a dynamic environment and monitor the response over time. Such tests can provide 
the kinetic information of the binding event, which can be utilized for the quantitation of BNP 
level. These investigations would finally lead to the development of biosensor system for patient 
to use it at home on a regular basis in future.  
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